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ABSTRACT

Investigations into factors affecting the WPD-loop in the protein tyrosine phosphatases
YopH and PTP1B
by
Gwendolyn Moise, Doctor of philosophy
Utah State University, 2018
Major Professor: Dr. Alvan C. Hengge
Department: Chemistry and Biochemistry

The research in this dissertation documents connections between the dynamics of
the WPD-loop and catalytic function in protein-tyrosine phosphatases (PTPs), and also
how both of these aspects of enzyme function are controlled by the amino acid sequence
in the mobile loop of PTPs. Catalysis in PTPs involves movement of a protein loop called
the WPD-loop that brings a conserved aspartic acid into the active site to function as a
general acid. Conservative mutation to the tryptophan (W) in the WPD-loop of YopH
lowers the catalytic activity by reducing the effectiveness of general acid catalysis. These
mutations lock the WPD-loop in a quasi-open position even when there is an oxyanion
ligand bound in the active site. Crystal structures show a novel divanadate glycerol ester
adduct in the active site that is not cleaved into the monomeric form because of the loss
of general acid catalysis. Mutations to the hydrophobic pocket, in which the indole side
chain of the tryptophan slides back and forth as the WPD-loop opens and closes, showed
that alterations cause significant 3 orders of magnitude or more loss in catalytic rate as
compared to the wild type YopH. None of the mutations where able to restore mobility to
the WPD-loop of the W354F mutant of YopH or lock it into the catalytically active
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position. Many of these mutations resulted in an insoluble protein, showing how
important the interactions of the tryptophan side chain with the hydrophobic residues are
for not only catalytic activity but also structural stability.
To examine the effect of amino acid sequence on the dynamics of the WPD-loop,
a chimera was created using YopH as the base enzyme in which the WPD-loop region
was swapped for the one in PTP1B. The construction of a stable chimera with catalytic
activity and functional general acid catalysis turned out to be more difficult than simply
swapping the designated loop regions. After many different swapped regions were made,
purified, and kinetically tested, one with significant catalytic activity was identified, and
was labeled YopH chimera 3. Using kinetic isotope effects it was shown that the
mechanism of hydrolysis had not changed from the native PTPs. The catalytic general
acid activity is fully restored, as shown by the bell shaped curve of the pH-rate profile,
however, the catalytic rate is 2 orders of magnitude slower than YopH, and 10-fold
slower than PTP1B. X-ray crystal structures showed that the WPD-loop of early chimeras
were in a novel unproductive position due to the extension of the adjacent alpha helix.
YopH chimera 3’s ligand-free structure shows the WPD-loop in the normal open
position, but the ligand-bound structure shows the WPD-loop in the extended alpha helix
position. Any time spent in the unproductive extended alpha helix position will reduce
the fraction of the protein present in a catalytically active conformation, reducing the
catalytic rate of YopH chimera 3 compared to that of either parent protein, but it is still as
active as many other native PTPs. In conclusion, the YopH chimera 3 is a fully functional
new and different PTP.
(156)
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PUBLIC ABSTRACT

Investigations into factors affecting the WPD-loop in the protein tyrosine phosphatases
YopH and PTP1B
Gwendolyn Moise

The research in this dissertation documents connections between the primary amino
acid sequence of proteins, the dynamics of proteins, and their catalytic function. This
research project studied two proteins called protein-tyrosine phosphatases (PTPs): the
human enzyme PTP1B, and the bacterial enzyme YopH. PTP1B is a human enzyme that
down regulates the insulin receptor on the outer cellular membrane, and causes the insulin
receptor to be less responsive to insulin. A deeper knowledge of how PTP1B is different
from other human PTPs might be useful in designing drugs to increase insulin sensitivity
in diabetics. Yersinia Pestis is the bacteria that caused the Black Plague, and YopH is an
essential for virulence factor that helps Yersinia Pestis to escape the human immune
response.
Using these proteins, the primary sequence of amino acids in a small but critical
loop region was altered and the effect on the catalytic efficiency was measured. This
research shows how some residues are key to the catalytic efficiency of PTPs while others
could be changed with little to no effect on the catalytic efficiency. A deeper understanding
of the difference between key residues and structural residues may allow future scientists
to create designer enzymes and perhaps design pharmaceuticals that mediate enzyme
activity by affecting their protein dynamics.
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LIST OF ABBREVIATIONS

Abbreviation

Definition

PTP

Protein Tyrosine Phosphatase, a sub family of phosphatases that
only dephosphorylates tyrosine residues

YopH

Yersinia outer protein H, a virulence factor from the bacterium
Yersinia pestis

IPTG

Isopropyl β-D-1-thiogalactopyranoside, a chemical mimic of
lactose used to induce bacteria, by binding to the lac operon, to
start production of a specified protein

DTT

Dithiothreitol, a chemical reducing agent added to buffers

p-NPP

para-nitrophenylphosphate, a small molecule substrate

SDS

Sodium dodecyl sulfate, a chemical used in making and running
of polyacrylamide gel electrophoresis

HEPES

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, a chemical
buffering agent

PEG

Polyethylene glycol, used in crystallography as a precipitation
reagent

EDTA

Ethylenediaminetetraacetic acid, metal chelating chemical used
to remove any free mental found in a buffer solution

DPS

Dual specificity phosphates, a sub family of the phosphatases
that dephosphorylate tyrosine serein and threonine residues.

KIE

Kinetic isotope effect, used to give a better understanding of the
mechanistic timing and overall mechanizes.

IRMS

Isotope ratio mass spectrometer, used in KIEs to find the ration
of heavy to light isotope in a sample

CHAPTER 1
INTRODUCTION

1. Protein tyrosine phosphatases: Biological importance and properties
Protein phosphorylation is an essential reaction used in a vast variety of biological
processes. The use of phosphorylation is ubiquitous in biology because it is a simple and
favorable reaction with a number of unique properties (1). The most notable property is
that, even though it is charged at biological pH, the half-life for hydrolysis of a phosphate
monoester at pH 7 and 25°C, is 1 trillion years (2). This makes the bond very stable and
only with the use of an enzyme as a catalyst is the bond breakable on the short time scale
needed in biological processes. Unlike many enzymatically catalyzed reactions,
phosphorylation is not reversible with the same enzyme. Protein kinases catalyze the
phosphorylation of a tyrosine, serine, or threonine residue to give a phosphorylated protein.
Phosphatases catalyze the reverse reaction, hydrolysis, of the phospho-ester bond releasing
the inorganic phosphate and a hydroxyl functional group on the surface of the enzyme.
This phosphorylation/dephosphorylation mechanism often functions as a switch to activate
or deactivate the enzyme. Because of the dichotomy between kinases and phosphatases
they have been called the yin and yang of cell signaling (3).
Eukaryotic cells have approximately 30% of their proteins phosphorylated (4).
The majority of the phosphorylation sites are threonine or serine residues. Tyrosine
phosphorylation, while only making up 0.01%-0.05% of the population, has been shown
to be up-regulated to 1%-2% of the total phosphoprotein population upon growth factor
stimulation (5, 6). While the total percentage of phosphorylated tyrosine is low there are
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over 100 protein tyrosine phosphatases (PTPs) in the mammalian genome (7). PTPs are
essential enzymes for many biological processes, including cell-cell communication,
metabolism, controlling normal cellular growth, differentiation, gene transcription, ion
channels, cell migration, cell survival, and immune response (8, 9). Numerous human
diseases are associated with abnormal protein tyrosine phosphorylation including cancers,
diabetes, rheumatoid arthritis and hypertension (10).
Members of the PTP enzyme family catalyze the dephosphorylation of
phosphotyrosine residues exclusively, not serine or threonine, and are found throughout
biology from prokaryotes to humans. Enzymes in the PTP family share many traits. All
PTPs have the same catalytic mechanism (Figure 1-1), the same key residues in the active
site for catalysis, superimposable active sites, and the same tertiary structure of the catalytic

Figure 1-1: The general mechanism of the PTP-catalyzed reaction. The WPD-loop
assumes a catalytically active, closed conformation with the general acid in position to
protonate the leaving group during the formation of the phosphoenzyme intermediate. In
the second step this intermediate is hydrolyzed. After the phosphate product is released,
the WPD-loop opens to a more favorable conformation (11).
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domain. However, PTPs share only 30% sequence conservation and their rates of catalysis
vary over three orders of magnitude. Because PTPs have so little similarity in their primary
sequence, genomics identification is very difficult. Once a potential PTP is identified and
purified the substrate specificity and structural characteristics are used to confirm or deny
its classification as a PTP (Figure 1-2).

Figure 1-2: All PTPs have a similar tertiary structure of the catalytic domain.
This is a structural alignment of the catalytic domains of six different PTPs. This figure
was made and aligned using Pymol where the active site P-loops were aligned. The
following PTPs were aligned: YopH in green, PDB ID 1YPT; PTP1B in blue, PDB ID
2F71; VHZ in purple, PDB ID 4ERC; Sso-PTP in yellow, PDB ID 2I6M; He-PTP in red,
PDB ID 1ZC0; and SHP2-PTP in gray, PDB ID 3ZM.
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The rest of this chapter will focus on PTPs in general, and specifically, on two wellstudied PTPs, PTP1B and YopH. PTP1B is a human enzyme that dephosphorylates the
insulin receptor on the outer cellular membrane, and causes the insulin receptor to be less
responsive to insulin. The vital role that PTP1B plays in the insulin response has been
heavily studied as a therapeutic target for type two diabetes and cancer (12-15). YopH is
a bacterial enzyme from Yersinia Pestis, and is a virulence factor that is secreted into the
host after infection that disables the host’s immune system. Yersinia Pestis is the bacteria
that caused the Black Plague which swept across Europe in the 14th century and killed
millions of people. The enzyme YopH, is not only essential for virulence in Yersinia, but
it is the fastest PTP known. Since the discovery of antibiotics, the threat of the Black Plague
has been reduced but there are still from one to two thousand cases of the infection reported
every year, mostly in central Africa (16). As well as being the fastest known PTP, YopH
prefers acidic environments, with optimum activity at pH 5.5. This is unusual because the
environment of the bloodstream is strictly controlled to a neutral pH. This is where Yersinia
Pestis infection normally starts by transmission from a flea of an infected rat or other
rodent. Once the infection is detected, the immune response triggers two types of cells,
macrophages and neutrophils. Macrophages engulf the infecting bacteria and phagocytize
via an acidic environment while neutrophils phagocytize via a basic environment. Yersinia
pestis, via the help of YopH and other virulence factors secreted using a type III secretion
system, is able to avoid the phagocytosis of the macrophages but not the neutrophils. This
preference for acidic environments of YopH has evolved to help Yersinia Pestis escape the
immune response of the macrophages (17-20).

5

2. Mechanism of PTP Dephosphorylation
Members of the PTP family of enzymes have a lot in common. PTPs only
dephosphorylate phosphotyrosine residues on proteins, and distinguishes PTPs from the
related dual-specificity phosphatases (DSPs) that dephosphorylate serine or threonine
residues in addition to tyrosine. Due to the depth of PTP active sites only the longer tyrosine
side chain is able to deliver the phosphoryl group into proximity of the nucleophilic
cysteine residue in the active site (Figure 1-3) (21, 22). All PTPs have the same three
catalytic residues: Cys, Arg, and Asp, and have the same catalytic mechanism (23). In this
mechanism, the substrate enters the active site where the conserved arginine, as well as
backbone amides, form hydrogen bonds with the oxygens on the phosphoryl group. This
helps to hold the phosphoryl group in place and stabilize the transition state. The
deprotonated, negatively charged cysteine at the bottom of the active site is the nucleophile
that attacks the electrophilic phosphorus on the phosphorylated tyrosine, which breaks the
scissile P-O bond to the bridging oxygen atom. The conserved aspartic acid that resides on
the mobile WPD-loop near the active site acts as a general acid to protonate the tyrosine
oxygen atom, neutralizing it as the P-O bond is cleaved, to form neutral tyrosine as the
leaving group. This leaves the enzyme with a phosphocysteine in the active site. The
second step of the reaction hydrolyzes the phosphocysteine phosphorus-sulfur bond. The
nucleophilic water molecule is deprotonated by the carboxylate of the same aspartic acid
residue. This process regenerates the free enzyme (Figure 1-1).
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Figure 1-3: Effect of active site width and depth, which explains the substrate
selectivity observed in different PTP subfamilies exemplified by (A) CDC14B (DSP),
(B) VHR (DSP), (C) YopH (PTP), and (D) VHZ (blue). The active site dimensions are
presented in Angstroms in the blue box below the measurements. Phosphoserinecontaining (orange) and phosphotyrosine-containing (green) peptides are modeled in the
active sites so that the P-loop-stabilized phosphate moiety is in catalytic proximity of the
nucleophilic cysteine, and the scissile bridging oxygen on the leaving group is within
hydrogen bonding distance of the catalytic general acid. The importance of the active site
depth for substrate selectivity is illustrated in the top row, whereas the bottom row reveals
the effect of the width. The backbone of the phosphoserine-containing peptide in panels C
and D is buried below the protein surface, indicating it clashes with several residues on the
edge of the active site. At the same time, the binding of the phosphotyrosine-containing
peptide reveals no such problem caused by the longer side chain. The importance of this
clash for the substrate selectivity is consistent with the reported ability of classical PTP
enzymes to catalyze monomeric alkyl phosphate esters, but not when they are part of a
peptide. Figure taken from reference (22).

The general acid needed for catalysis is not a part of the phosphate binding loop (Ploop), which the rest of the catalytic residues are found on. It is, instead, on the WPD-loop.
This protein loop is next to the active site and is called the WPD-loop because of three
highly conserved residues within the loop are tryptophan (W), proline (P) and aspartic acid
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(D). The WPD loop can move up to 12Å in distance from open to closed position. The
WPD loop is either in a catalytically active, closed position, or the open position farther
from the active site. Crystal structures suggest that in some PTPs the WPD-loop may
always be in the closed position, however, most are dynamic (Figure 1-4). In either
position the substrate can enter and leave the active site; the WPD-loop does not serve as
a lid to block the substrate from leaving or to close the active site off from the surrounding
solvent. The WPD-loop of the PTP family is highly important for its catalytic function.

Figure 1-4: The WPD loop open versus closed position relative to the active site, in
which the tungstate is bound in YopH and PTP1B is bound with a substrate analog.
Panel A is YopH WT ligand free structure with the WPD loop in the open position (PDB
ID 1YPY). Panel B is YopH WT with a tungstate ligand where the WPD loop is in the
closed position. Panel C is PTP1B ligand free structure with the WPD loop in the open
position. Panel D is PTP1B with a substrate analog ligand with the WPD loop in the closed
position. Figure from reference (30).
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3. Kinetics used to determine mechanism
Kinetics is an important technique used to analyze the rates of reactions to
understand the mechanism of catalysis. Although PTPs have many things in common, the
rates at which they catalyze the same reaction is not one of them. The rate varies over three
orders of magnitude. Rates of reactions can vary greatly, and these rates reflect the
efficiency of an enzyme. Conventional, steady state kinetics can reveal information about
catalytic efficiency and the overall turnover rate of an enzyme. The technique used to
measure the kinetics of PTPs in this work used the small molecule substrate paranitrophenylphosphate (p-NPP). This molecule is colorless when phosphorylated, but in
basic conditions, the hydrolyzed product, para-nitrophenol, (p-NP) turns bright yellow
with a max absorbance at 400 nM (24). This change in absorbance is monitored and can be
directly converted into the amount of product released over time. In order to perform a
kinetic reaction, the same concentration of enzyme is added to different concentrations of
substrate, then allowed to hydrolyze for a defined amount of time. The reaction is stopped
by the addition of a strong base which converts all of the freed para-nitrophenol to the basic
form and raises the pH to a level at which the PTP is no longer active, and at which the
background hydrolysis of pNPP is undetectable.
The absorbance is measured by a UV-Vis spectrometer at 400 nM and the blank,
which is a duplicate of each well’s substrate concentration without enzyme added, but with
the strong base to show any already hydrolyzed substrate, is subtracted from it to give the
total absorbance released over time. The absorbance is then converted to concentration
using the Beer-Lambert law and then divided by the duration of the reaction in order to

9

A = ɛ*l *c

Equation 1

v = Vmax * [S] / (KM + [S])

Equation 2

Table 1-1: Equations used for calculating the enzyme kinetics from the absorption of
the product chromophore. Equation 1 is the Beer-Lambert equation for calculating
concentration from absorbance were A is the absorbance, ɛ is the extinction coefficient, l
is the path length traveled, and c is the concentration of the measured material. Equation 2
is the Michaelis-Menten equation used to calculate the rate of enzymatic reaction, were v
is the reaction rate, Vmax is the maximum rate achieved when the enzyme is completely
saturated with substrate, KM is the Michaelis constant, and is the substrate concentration at
which the rate v is one half the Vmax, and [S] is the substrate concentration.

give a rate (Table 1-1). The rates are then graphed as a function of substrate concentration
and fitted to the Michaelis–Menten kinetics equation (Figure 1-5). This provides the Vmax
that is then divided by the enzyme concentration to give the kcat which can then be
compared to corresponding data for other enzymes.
Once the rate of the reaction at one pH is determined, the experiment can then be
repeated at other pH levels in order to determine the pH rate profile. The pH rate profile
for YopH shows not only the max rate for YopH at pH 5.5, but the bell shape typical for
all PTPs (Figure 1-6). This bell-shaped curve results from the involvement of two residues
needing to be in the correct protonation state for catalysis. If the solution is too basic, the
aspartic acid in the active site becomes deprotonated, removing the general acid. As a
result, the general acid is not present to neutralize the oxyanion being formed. Conversely,

Rate of
product
formed µM s-1
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Figure 1-5: A diagram of how the Michaelis Menten equation is plotted using the rate
of reaction at different substrate levels. Where Vmax is the maximum rate of the
asymptote curve, and Km is substrate concentration at one half the Vmax.

under acidic conditions, the nucleophilic cysteine in the active site becomes protonated and
can no longer act as the nucleophile, and as a result the PTP rate is slowed. The bell-shaped
curve shows that the mechanism requires both residues to be in the correct protonation state
to be maximally active. All PTPs have a pH optimum of between 5.5 and 6.5.
In PTPs the mechanism is a two-step process (Figure 1-1). The rate-limiting step is
the second step; therefore, the turnover number obtained from steady-state kinetics is
connected to the second step k5 (Table 1-2 Equation 3). In order to measure the rate of the
first, faster step, k3, stopped-flow kinetics is used to test for the presence of burst kinetics.
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Figure 1-6: Effect of pH on the pNPP hydrolysis reaction catalyzed by the wild-type
and mutant Yersinia PTPases. Circle is wild type, square is W354F and triangle is
W354A. The wild type YopH is faster than both of the mutants showing the importance of
general acid catalysis. The YopH W354A mutation is the slowest and the basic limb of the
pH rate profile’s normally bell-shaped curve is gone, indicating lack of general acid
catalysis. YopH W354F is between the two but more closely resembles the YopH W354A
mutant showing that general acid catalysis is not lost but greatly impaired (25).

Stopped-flow kinetics instruments can measure the very first turnover of the enzyme. High
enzyme concentrations are used and hundreds of absorbance measurements are taken
within milliseconds after the enzyme is mixed with the substrate. This data can then be
graphed and, if a burst is observed, 2 slopes will be identified. A burst is observed when
the first step is fast and the second step is slower and rate-limiting. The first slope is
correlated to the rate of the first step k3 and the second slope represents the overall turnover
rate and should match the steady state kinetics.
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Equation 3

Table 1-2: The catalytic mechanism of all protein tyrosine phosphatases. First the
enzyme binds to the substrate, then the enzyme breaks the ester bond of the phosphate
ester, leaving a covalently bonded phosphocysteine intermediate. The last step breaks that
bond releasing inorganic phosphate and free enzyme.

The third type of kinetics experiment used to study the mechanisms of PTPs is the
measurement of kinetic isotope effects (KIEs), which are used to give a greater
understanding of the mechanism and to determine bonding changes occurring in the
transition state. The uncatalyzed hydrolysis of phosphate monoesters have been shown to
go through a concerted reaction with a loose transition state (Figure 1-7) (26).
KIEs are excellent experiments to determine if mutations to the wild type enzyme
change the transition state or the mechanism. These experiments work by replacing an
atom on the substrate with a heavier isotope of the same atom. Heaver isotopes make a
stronger bond (with a lower vibrational energy) without changing any other properties of
the substrate, and therefore, will reduce a reaction rate if a bond is being broken to that
atom in the transition state (11). Such an isotope effect is called a primary kinetic isotope
effect. Secondary isotope effects can also be measured, and result if there are bond order
changes to the labeled atom in the transition state apart from a bond being formally formed
or broken to the labeled position.
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Isotope effect = log(1- 𝑓)/log((1- 𝑓)(Rs/Ro))

Equation 4

Isotope effect = log(1- 𝑓)/log((1- 𝑓)(Rp/Ro))

Equation 5

Table 1-3: The equations used to calculate the isotope effect with 𝑓 being the fraction
of the reaction of initial substrate used. Rs is the ratio of heavy isotope/light isotope in
residual substrate. Rp is the ratio of heavy isotope/light isotope in the product. Ro is the
ratio of heavy isotope/light isotope in the original sample.

KIEs for reactions of PTPs were measured using the substrate pNPP, labeled at the
position shown in (Figure 1-8). The KIE experiments were done on the PTPs using the
competitive method with remote labeling (27). In the competitive method, the enzyme
hydrolyzes a mixture of the labeled and unlabeled substrate. The reaction is stopped half
way and the product is separated, purified, and the ratio of the isotopes (Rp) is measured.
The residual substrate is also purified, and its isotope ratio (Rs) is also measured. The
isotope effect is calculated by the change in isotopic composition relative to the starting
reactant (Ro) using equations 4 and 5.
A reporter labeling method of the substrate is used to determine two oxygen
isotope ratios, because of characteristics of the isotope ratio mass spectrometer (IRMS)
system needed to measure the ratio of isotopes (Figure 1-9). The IRMS first combusts the
sample in the presence of oxygen, which converts the sample to the gasses CO2, H2O, and
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Figure 1-7: A diagram of the different pathways a phosphoryl transfer mechanism
can take. A transition state for phosphoryl transfer in which leaving group bond fission is
ahead of bond formation to the phosphoryl acceptor (in this case, water) is referred to as
loose, and resides in the lower right region. In the reverse situation, a tight transition state
results, in the upper left region. If the sum of the transition state bond orders to the
nucleophile and leaving group is unity, the transition state will lie on the synchronicity
diagonal.

N2 (the nitrogen oxides initially formed are reduced to nitrogen gas by a copper catalyst).
Therefore, the IRMS can only measure carbon, nitrogen and sulfur isotope ratios in gasses
such as N2, CO, CO2, and SO2 (Figure 1-10). In order to measure the 18O/16 O effect, the
nitrogen atom is labeled and used as a reporter for oxygen. The substrate is made with only
the bridging oxygen being labelled

16

O and the nitrogen atom labeled

14

N, and another

substrate is then labelled such that the oxygen’s label is 18O and the nitrogen atom is labeled
15

N. The 15N/14N ratio is measured by the IRMS therefore changes in the 18O/16O will be

reflected in changes in the 15N/14N ratio. This experiment will result in isotope ratios
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Figure 1-8: The positions where KIEs were measured using the substrate pnitrophenyl phosphate (pNPP). Showing the nomenclature of bridging and nonbridging
oxygen atoms in a phosphate ester, and the positions at which KIEs were measured (11).

Figure 1-9: Substrates for determining the bridging and non-bridging 18O KIEs. A is
labeled at the bridging position with 18O, and the nitrogen is also labeled with 15N, doubly
labeled with both of the heavy isotopes. B is labeled on all the non-bridging oxygens with
18
O, and the nitrogen is also labeled with 15N, doubly labeled with both of the heavy
isotopes. C is labeled with both the bridging and non-bridging oxygens being 16O, and the
nitrogen is 14N, doubly labeled with both of the light isotopes. A mixture of both A and C
in approximately naturally occurring 14/15N ratio is used to measure the bridging oxygen
KIE, while a mixture of B and C in approximately natural 14/15N ratios is used to measure
the non-bridging oxygen KIE.
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Figure 1-10: How the competetive KIE experiment is measured , and a schematic
diagram of the IRMS. On the top is a diagram of how the competetive method works.
The substrate is a mixture of 16O/18O labed p-NPP, and the enzyme added will partially
hydrolyze the substrate. The p-NP product (Rp) is then separated from the residual
substrate (Rs). Both samples are analyzed by IRMS. On the bottom is a diagram of the
conversion of the sample to a gas and why the remote labeling is necessary. The sample is
combusted over CrO3 in the presence of oxygen, then reduced over copper, to produce the
small molecule product gases CO2, N2, and H2O.
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resulting from the presence of isotopes at both the nitrogen position and the oxygen one.
In order to correct for the

15

N/14N replacement, the nitrogen KIE is first measured

separately (Figure 1-9).
The KIEs for the following PTP enzymes have been reported: YopH, PTP1,
PTP1B, VHR, STP1, and VHZ (Table 1-4) (11). The KIE of the bridging oxygen 18(V/K)
measures the degree of P-O bond cleavage in the transition state and indicates either a tight,
or loose transition state. This primary KIE can be as large as 1.03, and a significant
magnitude indicates the enzyme has a late transition state with nearly full bond fission to
the leaving group. The PTPs studied show a range of 1.01-1.017, because PTPs have a
loose transition state, but P-O bond cleavage is compensated partially by O-H bond
formation, resulting in a smaller isotope effect than would be observed if only bond
cleavage to the bridging oxygen were taking place (Table 1-4).

Kinetic isotope effects for reactions of members of the PTP superfamily with pNPP
Standard errors are in the range 0.0001–0.0008.
15
18
18
Substrate
Enzyme
(V/K)
(V/K)bridge
(V/K)nonbridge
YopH, PTP1, 0.9999–
VHR, PTP1B
1.0004
1.0118–1.0152
pNPP
Stp1
1.0007
1.0171
pNPP
VHZ
1.0013
1.0164
Table 1-4: Kinetic isotope effects for reactions of members of
with pNPP. Standard errors are in the range 0.0001–0.0008 (11).
pNPP

0.9998–1.0018
1.0007
0.9986
the PTP superfamily

18

The nitrogen atom in the para position is not directly involved in the bond breaking
events, but can result in a secondary KIE because of resonance. If the bridging oxygen
becomes negatively charged during the transition state, the charge will be delocalized
through the phenol ring to give a quinonoid resonance structure involving the nitrogen
atom, resulting in a small but measureable isotope effect.
The KIE in the nitrogen position

15

(V/K) of the native PTPs is unity, within

experimental error, which means that there is no isotope effect, therefore, there is no charge
built up on the phenyl ring (Table 1-4). This indicates that the aspartic acid that acts as a
general acid in the active site is fully neutralizing the leaving group in the transition state.
The data indicate YopH, PTP1B, PTP1, and VHR all have fully functioning general acids,
however, in Stp1 and VHZ, the protonation lags behind P-O bond fission, causing a
measureable KIE in the nitrogen position. This may also explain the slower reaction rates
of these PTPs. The oxygen 18(V/K) nonbridging KIEs are all near unity, showing that the
P-O pi bond is not broken. This is not consistent with an addition-elimination process and
is more consistent with a concerted SN2 type of process, through a metaphosphate-like
transition state. All of the KIEs recorded for PTPs show that the interaction of the
phosphorylated substrates with the active site has not altered the transition state from the
uncatalyzed reaction (11, 28).
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KM (mM) as function of pH
Reaction
PTP1B
wildtype

kcat (s-1) as function of pH

5.5

6.5

7.5

5.5

6.5

7.5

0.58(2)

1.48(2)

2.20(1)

24.4(2)

17.1(1)

3.48(1)

PTP1B W179F

0.93(5)

0.86(3)

1.04(5)

11.8(2)

2.42(2)

0.151(3)

PTP1B
W179A

4.41(9)

3.94(3)

2.85(5)

0.0750(5) 0.0667(1) 0.0370(2)

YopH wildtype

2.00

601

95.5

11.0

YopH W354F

4.82

296

1.42

1.10

YopH W354A

3.85

1.26

1.23

1.07

Table 1-5: Kinetic parameters for YopH and PTP1B. Top, kinetic constant at different
pHs for pNPP hydrolysis catalyzed by the wildtype PTP1B and tryptophan 179 mutants at
23C. Bottom, kinetic constants for the reaction of pNPP by the wild type YopH, and of
proteins with mutations to the corresponding residue W354. Values in parenthesis are the
standard deviation in the last decimal place (23).

4. Differences in the rates of motion of WPD-loops in PTPs.
As mentioned earlier, enzymes in the PTP family have a lot in common: the same
catalytic mechanism, superimposable active sites, and the same residues used in catalysis.
However, the PTP family has varying catalytic rates. Because of the similarities across the
PTP family, finding a drug that only targets one PTP has been very difficult. Investigation
in how the catalytic rates differ and the role WPD-loop has in the catalytic rate, could help
differentiate PTP family members. If an inhibitor could be designed to only target one PTP
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then the side effects of this type of drug would decrease dramatically. Studies were done
that observed the effects of mutations to the conserved tryptophan residue of the WPDloop in YopH, W354F and W345A (29) (30). The W354 residue is located at the end of a
WPD-loop region that contains the aspartic acid which acts as a general acid. The study
found that mutations to the residue W354 reduced the overall rate of catalysis by nearly 3
orders of magnitude (Figure 1-6). When the corresponding mutation was made in PTP1B
of this tryptophan to phenylalanine (W179F), a conservative mutation, the rate is only
reduced by 2-fold. In contrast to the phenylalanine mutations, the alanine mutations,
PTP1B to W179A and YopH to W354A, reduces the rate by 3 orders of magnitude in both
(Table 1-5).

Figure 1-11: A comparison of native and W354F YopH structures. Superpositions
comparing the WPD conformations of the open WPD-loop: apo native YopH (1YPT,(16)
red) and the quasi-open WPD-loop: structures of YopH W354F apo form (in cyan) and in
complex with divanadate (blue) and tungstate (orange). Closed WPD-loop: structure of
native YopH in complex with tungstate (1YTW, green) (17). The image on the left is a
magnification of the inset outlined on the right (31).
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To discover why the rate was lowered in PTP1B W179F but not YopH W354F,
crystal structures were solved (31). In crystal structures of native PTPs, the WPD-loop is
found in two different positions depending on whether a ligand is bound in the active site
or not. The WPD-loop is in the active, closed position if there is a vanadate, tungstate, or
other oxyanion in the active site, but, if there is nothing bound in the active site, the WDPloop is most often found in the open position which pulls the general acid out of the active
site. In the mutant YopH W354F the crystal structures with vanadate or tungstate show
the loop in a new quasi-open position (Figure 1-11). YopH W354F crystal structures
without a ligand bound show the WPD-loop in a very similar quasi-open position. In the
structure with the WDP loop in the quasi open position, the general acid is out of the active

Figure 1-12: Binding environment for tungstate (A) and divanadate (B) in the active
site of W354F YopH. Hydrogen bonds are shown by dashed lines, and the acceptor−donor
atom distances are shorter than 3.2 Å. Inset: Composite omit electron density map for
divanadate generated at 1.5 σ contour level (32).

22

site and not functional, consistent with the pH-rate profile data. These results show that
the W residue at the beginning of the WPD loop, while not part of the mechanism, is
important for the rate, because it controls the position of the general acid that is part of the
mechanism.
In 2008, Brandao et al. reported the first structure with a quasi-open loop and
divanadate in the active site of a mutant of YopH. Vanadate is a strong inhibitor of all
phosphates because it can stably form a penta-coordinated trigonal bipyramidal geometry
that mimics the transition state (33). The divanadate structure is only seen in crystal
structures where the WPD-loop is in the quasi-open position (Figure 1-12). This is because
the when the WPD-loop is active and in a closed position, the general acid would catalyze
the decomposition of any bound divanadate, leaving the vanadate in the monomeric form
with the oxygen of the aspartic acid making a hydrogen bond were the second vanadate
atom would be.
To determine the rate at which the WPD-loop moves, in 2013 Whitter et. al.
measured YopH and PTP1B WPD loop dynamics using protein NMR (34, 35). The loop
dynamics of wild type YopH and PTP1B were measured for the free enzymes and with a
bound non-hydrolyzable substrate analog. This allowed measurements of the rates of the
loop closure, kclose, and opening, kopen. The results showed that the WPD-loop movements
in the two enzymes correlate with their rates of catalysis, especially the first step kcleave
which corresponds to k3 in Equation 3 (Table 1-6). Whitter et. al. found that the WPD-loop
in YopH moves faster than the WPD-loop in PTP1B.
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Table 1-6: The NMR rates of WPD loop movement show that the faster the WPD loop
can close the faster the rate of the enzyme. On the left is a picture of the WPD loop of
PTP1B in the open position (gray) and the closed position (blue). Then general acid side
chain is shown and labeled. The P-loop is shown in orange and the vanadate in the active
site is shown in a space filling model. On the right is a table of the loop dynamic rates
measured by NMR at room temperature and pH of 6.0.

The following chapters will discuss the continuing research which looks at how
factors affecting the WPD loop motions in PTPs, particularly YopH and PTP1B, are linked
to their catalytic rates. In chapter two, the crystal structures of YopH W354H and W354Y
were solved and show that the WPD-loop is in the quasi-open position. In the active site
the discovery of the divanadate glycerol ester is also reported. Chapter three presents
results for YopH chimeras containing the WPD loop of PTP1B instead of its own, showing
how this interchange affects the WPD-loop and the effect on catalysis. This new protein
has an even slower rate than either YopH or PTP1B but is still active. The interactions
between the WPD loop and the active site are critical for PTP catalysis. Chapter four
presents results from mutations to the hydrophobic pocket that is under the active site and
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within which the side chain of the tryptophan of the WPD loop slides when the loop moves.
While most of the mutants have significant issues in purification and catalysis, it shows
how important these residues are to the protein. The final chapter summarizes future
experiments that can be done to further understanding of PTP hydrolysis.
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CHAPTER 2
CONSERVATIVE TRYPTOPHAN MUTANTS OF THE PROTEIN TYROSINE
PHOSPHATASE YOPH EXHIBIT IMPAIRED WPD-LOOP FUNCTION AND
CRYSTALIZES WITH DIVANADATE ESTERS IN THEIR ACTIVE SITES1

Abstract
Catalysis in protein-tyrosine phosphatases (PTPs) involves movement of a protein
loop called the WPD-loop that brings a conserved aspartic acid into the active site to
function as a general acid. Mutation of the tryptophan in the WPD-loop of the PTP YopH
to any other residue with a planar, aromatic side chain (phenylalanine, tyrosine, or
histidine) disables general acid catalysis. Crystal structures reveal these conservative
mutations leave this critical loop in a catalytically unproductive, quasi-open position.
Although the loop positions in crystal structures are similar for all three conservative
mutants, the reasons inhibiting normal loop closure differ for each mutant. In the W354F
and W354Y mutants, steric clashes result from six-membered rings occupying the position

1

Coauthored by Gwen Moise, Nathan M. Gallup, Anastassia N. Alexandrova, Alvan C.
Hengge, and Sean J. Johnson. Reproduced with permission from The Journal of the
American Chemical Society: Biochemistry. Vol 54 (42), 6490-6500 DOI:
10.1021/acs.biochem.5b00496. copyright 2015 American Chemical Society. The
computational studies including the electronic structure parameters for the divanadate
glycerol ester, were done by Nathan M. Gallup, Anastassia N. Alexandrova at UCLA. The
experimental work including the kinetics and crystallography, were done by Gwen Moise,
under the supervision of Alvan C. Hengge, and Sean J. Johnson at USU.
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Figure 2-1: TOC graphic showing that all conservative mutations to the WPD-loop
tryptophan, keep the loop from closing.

of the 5-membered ring of the native indole side chain. The histidine mutant dysfunction
results from new hydrogen bonds stabilizing the unproductive position. The results
demonstrate how even modest modifications can disrupt catalytically important protein
dynamics. Crystallization of all the catalytically compromised mutants in the presence of
vanadate gave rise to vanadate dimers at the active site. In W354Y and W354H, a
divanadate ester with glycerol is observed. Such species have precedence in solution and
are known from the small molecule crystal database. Such species have not been observed
in the active site of a phosphatase, as a functional phosphatase would rapidly catalyze their
decomposition. The compromised functionality of the mutants allows the trapping of
species that undoubtedly form in solution and are capable of binding at the active sites of
PTPs, and, presumably, other phosphatases. In addition to monomeric vanadate, such
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higher order vanadium-based molecules are likely involved in the interaction of vanadate
with PTPs in solution.

Introduction
Protein tyrosine phosphatases (PTPs) catalyze the dephosphorylation of Tyr
residues, functioning in concert with protein tyrosine kinases (PTKs) to modulate signal
transduction pathways. (1-4) One of the most-studied PTPs is the Yersinia protein tyrosine
phosphatase YopH. YopH is an essential virulence factor in Yersinia, a bacterial genus
that includes three species causative of human illness, ranging from gastrointestinal disease
to Bubonic Plague. (5) YopH is also one of the most powerful phosphatases known, with
kcat values of about 1300 s-1 for physiological phosphopeptide substrates at 30 °C.(6, 7)
Given the rate constant of ~10-20 s-1 for the uncatalyzed hydrolysis of phosphate monoester
dianions, YopH is one of the most efficient enzymes known. (8) Another well-studied PTP
is PTP1B, a human phosphatase with a number of roles that include regulation of the
insulin receptor protein. PTP1B and YopH have highly superimposable active sites and the
same mechanism, although catalysis by PTP1B is an order of magnitude slower.
PTPs catalyze the hydrolysis of tyrosine phosphate esters by a two-step mechanism
(Figure 2-2) via a phosphoenzyme intermediate.(2, 3) The phosphoryl group binds in a
conserved element known as the P-loop, a signature motif with the sequence CX5R that
includes the nucleophilic cysteine, a conserved arginine, and a semicircular arrangement
of backbone amide groups. Substrate binding in PTPs favors the closed conformation of a
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flexible loop bearing the conserved sequence WPD. This loop contains a conserved
aspartic acid that functions as a general acid in the first chemical step, and as a general base
in the second one (Figure 2-2).(9, 10) In the closed conformation, the WPD-loop brings
the conserved Asp residue up to 8 Å closer to the bound substrate.(11-15) Although the
loop-open and -closed forms of the active sites of YopH and PTP1B superimpose well with
one another, the loops move at significantly different rates in the two enzymes, and respond
differently to mutation of the W residue.(16) The W354F mutant of YopH has lost general
acid catalysis and crystallizes with this loop in an intermediate, quasi-open position. In
contrast, the corresponding W179F mutation in PTP1B has no significant structural effect,
and a minor reduction in rate.(17)

Figure 2-2: Mechanism of hydrolysis by protein-tyrosine-phosphatases (PTPs). In the
first step nucleophilic attack by a conserved cysteine is concerned with leaving group
departure and protonation by aspartic acid. Subsequent hydrolysis of the phosphocysteine
intermediate regenerates’ free enzyme.
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Crystal structures of the W354F mutant of YopH obtained in the presence and
absence of ligands show the same quasi-open loop position. Furthermore, a structure
obtained with vanadate revealed a bridged divanadate molecule at the active site.(18) Such
a species would be rapidly hydrolyzed by general acid catalysis in the native enzyme,
leaving behind the monomeric form typically observed in the active sites of phosphatases
crystallized in the presence of vanadate. Thus, the loop-compromised mutant permitted
the visualization of a vanadate species that likely forms and competes with substrate in
solution, but has not been observed in crystals of a functional phosphatase. The W354F
instance was the first such example of which we are aware.
We report here results with two additional mutations to YopH that also impair the
WPD loop and disable general acid catalysis. Crystals of these enzymes show the presence
of an ester complex formed between divanadate and glycerol; the latter was added only
after crystallization, as a cryoprotectant.

These results demonstrate that vanadate

oligomers bind to PTPs, and that interactions with ester-forming molecules in solution can
rapidly result in new species bound at the active site. Previous studies have shown that
effects from confinement, and local interactions with membrane interfaces, have effects on
the coordination chemistry of vanadium.(19, 20) It is, therefore, not surprising that an
active site environment can provide stabilization to species not observable in solution. A
computational analysis of the bonding in the divanadate-glycerol ester was performed to
examine how it differs from analogous complexes in small molecule crystals, and
compared to divanadate alone. The results provide insight into the effect of the active site
environment on the formation and stability of such species.
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Together, the results reported here give new insights into how even conservative
mutations affect WPD loop movement in YopH, provide new examples of oligomeric
vanadate species that can form and occupy the active site of PTPs, and reveal how the local
environment affects the chemical bonding of such species. The computational results
permit a comparison of how bonding within the divanadate moiety is affected by
coordination with glycerol, and how these protein-bound species compare with analogous
structures found in the small molecule crystal database.

Experimental Procedure (Material and Methods)
Chemicals
IPTG and DTT where purchased from GoldBio. All other buffers and reagents
were purchased from Sigma-Aldrich.

p-NPP was made and purified as previously

described.(21) Crystal trays and cover slips were purchased Hampton research.
Protein Expression and Purification
The YopH mutants were made using the Qiagen QuikChange Lighting Site–
directed Mutagenesis Kit. Primers were designed according to directions in the protocol.
The W354Y and W354H mutations were introduced using complimentary primers where
the primers in the forward direction were (GTG GTT CAT GTT GGC AAT TAT CCC
GAT CAG ACC GCA GTC AGC) and (G GTT CAT GTT GGC AAT CAT CCC GAT
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CAG ACC GCA GTC AGC TCT G) respectively. Both mutants where expressed and
purified as previously described and showed 99% purity on an SDS page gel.(18)
Crystallography
Crystals were grown by hanging drop vapor diffusion at room temperature (22⁰C).
Both the YopH mutants W354H and W354Y crystals were grown with the well solution
of 0.1M HEPES buffer pH 7.5, and 15-28% polyethylene glycol (PEG), 3350. The crystals
grew best in the higher PEG range (20~26%) but crystals can be seen throughout the range.
The drop consisted of 2µL of well solution and 3µL of protein solution (15mg/mL of
enzyme in 100mM sodium acetate, 100mM NaCl, 1 mM EDTA, and 1 mM DTT). Crystals
appeared in 3-5 days. Crystal optimization was achieved by microseeding. Crystals were
prepared for cryo-cooling by transferring them into a stabilization solution containing
increasing concentrations of glycerol, starting at 0% and increasing by 5% increments to a
final concentration of 20% glycerol (5 minutes/step). The crystals were then flash frozen
in liquid nitrogen and stored under liquid nitrogen.
Crystals in complex with vanadate were grown by incubating protein with sodium
metavanadate (Na3VO4) at a 1:5 molar ratio, where protein/Na3VO4 solution was left to
interact for 30 minutes on ice prior to co-crystallization. A stock solution of Na3VO4 was
made up to a concentration of 106.4mM in dilute NaOH as previously described(22) and
mixed with the protein solution, then the combined solution was added to the drop. The
concentration of the sodium metavanadate solution was checked by UV spectroscopy at
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Table 2-1: Data Collection and Refinements for W354Y and W354H YopH Ligand free
and Co-crystallized Oxyanion-Bound Form
W354Y
Ligand free

V2O7

W354H
Ligand free

V2O7

Data collection
beamline
Wavelength (Å)
space group
unit cell dimensions (a, b, c,
(Å); α = β = ϒ = 90ᵒ)
resolution range (Å)
outer shell (Å)
no. of reflections
unique
total
average redundancy
mean I/σ(I)
completeness (%)
Rmerge (%)

SSRL 7-1
0.97946
P212121
52.9, 60.5,
89.4

SSRL 7-1
0.97946
P212121
54.4, 58.0,
90.5

SSRL 7-1
0.97946
P212121
53.3, 60.6,
89.3

SSRL 7-1
0.97946
P212121

50.0-1.05
1.09-1.05

50.0-1.12
1.16-1.12

40.0-1.20
1.24-1.20

50-1.12
1.16-1.12

133,901
1,495,665

106,319
1,071,240

90,707
1,281,329

109,639
1,253,588

8.9
48.3(4.7)
99.7(100.0)
0.036(.414)

10.1
46.7(6.1)
96.2(78.0)
0.040(.218)

14.1(12.5)
24.9(5.2)
99.4(97.4)
0.096(0.53)

11.4(10.5)
52.8(10.4)
99.4(99.2)
0.064(0.723)

52.8, 60.4, 89.3

Refinement
Rwork/Rfree (%)
Atoms in the Structure
total
protein
waters/solvent
ligands/ions
B-factors (Å2)
Average
Protein
water/solvent
Ligand
Bond (Å)
Angles (ᵒ)
Protein Geometry
Ramachandran outliers
(%)
Ramachandran Favored
(%)
Rotamer outliers (%)
PDB ID

0.128/0.140

0.129/0.145

0.140/0.159

0.141/0.159

5295
4839
456
0

5005
4530
457
18

5039
4644
395
0

4996
4586
392
18

14.83
12.40
27.91
.008
1.32

15.48
12.92
28.34
23.26
.009
1.28

18.56
15.99
33.75
0.009
1.35

20.01
17.49
34.67
18.25
0.008
1.29

0.0

0.0

0.0

0.0

98.17

97.3

97.9

98.3

0.0
4YAA

0.0
4ZN5

0.0
4Z6B

0.8
4ZI4
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260 nm.(23) Vanadate-bound crystals grew best in the lower PEG range (16-20%) and
microseeding was required to obtain crystals.
Data collection and validation
Crystals were screened on a home source X-ray system, and diffraction data were
collected at the Stanford Radiation Lightsource (SSRL). Data were processed using
HKL2000(24). Molecular replacement was performed with Phaser (25)(as implemented in
either CCP4 (26)or Phenix(27)) using WT YopH (PDB ID 1YPT)(28) as a search model.
Model building, refinement, and validation were performed using Coot (29), Phenix (30),
and MolProbity (31). The structures are deposited into the protein data bank as 4ZN5,
4YAA, 4ZI4, and 4Z6B (Table 2-1). Pymol (32) was used to align structures and create
figures.

Kinetics
The pH-rate profiles for the WT YopH and both mutants were collected using real
time and endpoint kinetics in the pH range of 4.5-8.5 with the substrate p-nitrophenyl
phosphate (pNPP). The conditions were 0.1M buffer base mix (100mM sodium acetate,
100mM tris, and 100mM HEPES). Substrate concentrations ranged from one eighth to five
times KM. Unless otherwise specified, inhibition experiments were conducted at the pH
optimum of 5.5 at 23 °C in a 96 well plate, 100mM acetate buffer and 100mM sodium
chloride with 1mM DTT. The vanadate inhibitor concentrations ranged from 0.01-5.0 µM.
Substrate concentrations ranged from 0.30-12 mM p-NPP. Formation of p-nitrophenol
from pNPP was assayed at 400nm using a VersaMax 96 well microplate reader. End point
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reactions were quenched with the addition of 10N NaOH after reaction times ranging from
1.5 to 30 mins. Glycerol inhibition experiments were carried out using a vanadate
concentration of 32 µM at pH 5.5 with concentrations of glycerol from 0-275mM (Figure
2-S3). Enzyme concentrations in stock solutions were determined using a NanoDrop ND1000 spectrophotometer.

Computational Methods
For both W354F and W354Y, the relevant region was extracted from the enzyme for
computational study. This region consisted of residues that interacted directly with the
vanadate and vanadate-glycerol complexes, as well as charged and polar residues in
proximity that may provide electrostatic influences. Hydrogen atoms were added using the
Chimera program(33) while protons on the vanadate complex were added by hand using
in both W354F and W354Y was assumed to be deprotonated, as well as the coordinating
Avogadro(34). All protonation states of amino acids were assumed, while coordinating
Cys oxygens contributed by glycerol in W354Y. The truncated complexes consisted of
approximately 150 atoms each. The spin states were considered to be singlets, assuming
the d subshell in V to be empty. Natural bond orbital (NBO) analysis(34-38) at the
B3LYP(39-41)/TZVP(42) level of theory was used to evaluate the chemical bonding in the
complexes. Optimizations were performed using Turbomole V6.3(43) using the similar
def2-TZVP basis set(44, 45). To speed up calculations, the Resolution of Identity (RI)(46),
and Multipole Accelerated Resolution of Identity (MARI-J)(47) were used. Empirical
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dispersion was included(48) and solvent was included via the Conductor-like Screening
Model (COSMO)(49) with a dielectric constant of 20, since the complexes are partially
solvent accessible. NBO calculations were performed using the Gaussian 09 suite of
programs(50, 51). Several protonation states were tested for both enzymes. For W354F,
protonation on O4, O5, and O7 were attempted, however only O5 was able to be
successfully converged. The rest were not found to be minimum and resulted in ring
breaking upon optimization from various protonation configurations.

For W354Y,

protonation on O5 and O6 was attempted, but were found to have an energetic difference
of less than a single kcal/mol, within the inherent error of DFT.

Figure 2-3: A comparison of YopH WT with mutants W354Y (A) and W354H (B) with
vanadate (WT) or divanadate glycerol ester (mutants). The ligand-free, open-loop YopH WT
is black, the vanadate-bound, closed-loop YopH WT is light gray. The W354F, with its loop in a
quasi-open position, is dark gray. (A) The ligand-free W354Y structure is shown in purple, the
divanadate glycerol ester bound form is red. (B) The ligand-free W354H structure is purple and
the divanadate glycerol ester bound form is red. The ligand-bound forms of both W354Y and
W354H show the WPD-loop in an unproductive quasi-open position, consistent with kinetic
results.

Results
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Comparison of the WPD loop positions in W354Y and W354H with one another, and
with previous structures of W354F and WT
The crystal structures of W354H, with and without a bound ligand, showed the
WPD loop in a quasi-open position (Figure 2-3) similar to that previously reported for the
W354F mutant(18). A very similar position is found for the WPD-loop in the W354Y
mutant, with only slight variation of the loop’s configuration in the ligand-free structure.
Steady state kinetics for W354H and W354Y
The W354H and W354Y mutants exhibit Michaelis-Menten saturation kinetics
with the substrate pNPP, though at a significantly reduced rate than WT YopH. The kcat
values at 23 °C for the W354H and W354Y mutants at pH 5.5 are 5.2 ± 0.6 and 2.3 ± 0.1
s-1, respectively, compared with 720 ± 5 for WT. The pH optimum is 5.5 for WT and
W354H, whereas the W354Y mutant has a slightly shifted pH optimum of 6.2, where its
kcat is 6.5 ± 0.9 (lower panel, Figure 2-4). The KM values for the W354H and W354Y
mutants at pH 5.5 are 7.07 ± 1 mM and 6.4 ± 0.9 mM, respectively, higher than the 1 mM
KM for WT. In both mutants the basic limb of the pH-rate profile is largely lost, with the
rate above the maximum dropping off only slightly before leveling off (Figure 2-4). This
is consistent with previously reported data from the W354F mutant, in which the general
acid D356 is no longer fully functional.(18, 52)
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Figure 2-4: The effects of pH on the hydrolysis of p-NPP by YopH Mutants W354Y and
W354H compared to WT YopH at 23 °C. The W354Y data are shown as blue squares, W354H
as red circles., and WT as green diamonds The upper panel shows the comparative kcat values in
the mutants compared to WT YopH are lower by over two orders of magnitude and the basic limb
of the pH profile is lost. The lower panel shows that the mutant kinetic data decrease only slightly
at pH values above their respective maxima, similar to previous data reported for the W354F
mutant.(18)
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Observation of divanadate glycerol esters at the active sites of W354H and W354Y
The YopH W354H and W354Y crystals grown in the presence of vanadate showed
electron density consistent with a divanadate species. A similar divanadate moiety was
previously observed in the W354F mutant(18). However, the electron density in the YopH
W354H and W354Y structures also showed the presence of a glycerol molecule with two
oxygen atoms occupying coordination sites (Figure 2-5). In the divanadate glycerol ester,
atom V1 is coordinated to the sulfur atom of cysteine C401. Oxygen atoms O1 and O2 are
hydrogen bonded to backbone amide N-H groups of P loop residues R402, A403, V405,
and G406. Oxygen atom O3 bridges V1 and V2 and is hydrogen bonded to the backbone
amide and the ε nitrogen of R409.

Atoms O5 and O6 are the terminal oxygen atoms

bonded to V2. The crystals were grown at pH 7.5, making it likely that either O5 or O6 is
protonated. In the crystal, O5 is hydrogen bonded to two water molecules while O6 is
hydrogen bonded to the amide N-H of residues Q446 and Q450 with a distance of 2.9Å
(Figure 2-6). Therefore, O5 is assumed to be protonated and O6 is not. Compared to the
dimeric vanadate in the W354F structure (Figure 2-5 B), in the glycerol esters found in the
present work, atoms O4 and O7 have been replaced by oxygen atoms from the glycerol
ester where O4 is the bridging atom between V1 and V2 and O7 is bonded to V2. The
electron density map in (A) shows a gap between oxygen atom O7 and V2.
Bonding differences of the divanadate core in the glycerol ester
The divanadate core in the glycerol ester structure (Figure 2-5A) is generally
similar to the previously reported structure of divanadate alone in the W354F mutant
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Figure 2-5: Structural comparisons of the divanadate glycerol ester observed in the
active site of W354Y with other divanadate species. (A) 2Fo-Fc electron density map
for the divanadate glycerol ester in the active site of W354Y at 1.0σ contour level. The
divanadate ester in W354H is identical. (B) Simulated annealing omit map at 1.0σ contour
level calculated with the divanadate ester omitted from the model. (C) The divanadate
previously seen in YopH W354F. (D) Bond distances for each type of bond is shown in Å
with 2.5 Å for the S-V bond, and 1.9 Å for indicated V-O bonds. (E) For comparison, a
known small molecule divanadate(53) with bond distances for corresponding bonds in
Angstroms.

(Figure 2-5B), but there are significant differences in some bond angles between oxygen
and vanadate, as shown in (Table 2-2). Overall, the W354F divanadate has a more flattened
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geometry in the terminal oxygens. The position of O5 is different in the glycerol ester,
farther away from the bridging O3 and closer to the glycerol oxygen O7.

Kinetics in the presence of vanadate and added glycerol
The inhibition by vanadate of the YopH(W345H) with the substrate pNPP was
measured in the presence of zero to 275 mM glycerol. Glycerol alone does not inhibit
YopH W354H (Figure 2-S3), and added glycerol did not enhance inhibition by vanadate.
The kcat at 32 µM vanadate (10 x the Ki) was 0.071 s-1 in the absence of glycerol, and did
not significantly change over the glycerol range tested (Figure 2-S3).
Computational analysis of vanadate complexes
The divanadate glycerol ester found in the present study of W354Y, and the
divanadate complex found in a previous study of the W354F mutant, were analyzed
computationally. The glycerol ester was modeled assuming either protonation on O5 or
O6, however, as described above, on the basis of hydrogen bonds observed in the crystal,
protonation on O5 is more likely.

In the simple divanadate complex from W354F

protonation was modeled on O5. Table 2-3 outlines the nature of chemical bonding within
each complex. The inconsistent nature of the bond populations suggests significant
delocalization within the ring, which precipitates numerical error using NBO analysis.
NBO’s inability to characterize this delocalization is best illustrated by the alleged
existence of four lone pairs on O4 in the W354F complex. The decreasing populations of
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each respective orbital suggest the presence of a highly ionic oxygen atom. Results have
also been shown to be basis set dependent, also suggesting a failure to accurately
characterize delocalization in the ring.

Figure 2-6: A stereo figure showing the hydrogen bond network in the active site of
the W354Y mutant with the divanadate glycerol ester bound. The hydrogen bonds are
shown as dashed black lines where the distances are between 2.8-3.1Å. Vanadate atoms
are gray, the glycerol ester is in teal, and the enzyme is pink. The hydrogen bond network
stabilizes the divanadate glycerol ester.
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Discussion
All conservative mutations to W354 in YopH compromise general acid catalysis.
Published crystal structures of native YopH WT with an oxyanion ligand bound have the
WPD-loop closed over the active site, in the catalytically active position(54). In contrast,
WT structures with no bound ligand show the WDP loop in an open position (Figure 23).(54) It was previously found that the W354F mutant crystallizes with the WPD-loop in
a quasi-open position, in which the top of the loop has shifted only ~2.0Å away from the
open WPD-loop towards the closed position(18). That structural result explained data from
pH-rate profiles and kinetic isotope effects indicating that general acid catalysis was lost
in the W354F mutant.

Those results were surprising in light of the fact that the

corresponding mutation to the conserved tryptophan in the WPD-loop of PTP1B has only
a minor effect on rate, and does not compromise general acid catalysis.
In the present work, the reduced rates and pH-rate profiles of the W354H and
W354Y mutants are also consistent with WPD loops that cannot achieve the catalytically
functional closed position needed for general acid catalysis. The pH rate profile of WT
YopH (Figure 2-4) shows the bell curve characteristic of PTPs, which, on the acidic limb,
gives the pKa of the cysteine nucleophile, and the basic limb gives the pKa of the aspartic
acid.(52) The closed WDP loop in WT structures with bound oxyanion inhibitors show the
general acid D356 within hydrogen bonding distance of an apical oxygen of the bound
ligand corresponding to the position of the scissile oxygen of the tyrosine leaving group in
the first step of the reaction. When the WPD loop is in the quasi-open position seen in the
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W354H and W354Y mutants, the D356 side chain is out of hydrogen bonding range and
can no longer perform as a general acid (Figure 2-S4).
Divanadate species are consistently observed in crystal structures of loop-locked
YopH, but never in native PTPs
Vanadate modulates a number of biological processes, generating interest in the
origin of its interactions with proteins.(55-62) In particular, vanadate is a potent inhibitor
of many phosphatases, and its insulin mimetic effect is ascribed to its inhibition of
PTPs.(63, 64) An understanding of these effects is complicated by the tendency of vanadate
to oligomerize.(65) Inhibitory effects are observed under conditions where vanadate is
primarily oligomerized and the monomer is a minor form.(57, 65) The reaction of vanadate
with organic molecules containing hydroxyl groups to form esters is well known. NMR
has been used to document the formation of binary and ternary complexes with
monodentate and bidentate ligands in aqueous solution. Such species are of variable
stability and exist in an equilibrium that is pH-dependent. Even vanadate tetramers have
been implicated as important inhibitory species in vitro and in vivo.(57, 65-67)
Even

though

protein

crystallization

conditions

often

require

vanadate

concentrations that would primarily result in oligomeric species, such structures almost
exclusively show monomeric vanadate at the active site. In WT YopH vanadate structures,
bound vanadate is a penta-coordinated monomer that resembles the transition state for
phosphoryl transfer. This has been attributed to the facile interconvertability of different
vanadate species in solution, and the ability of the active sites of phosphatases to selectively
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stabilize the monomeric form.(68)

However, active PTPs should catalyze the

decomposition of any dimeric forms that bind in solution, using the same mechanism and
catalytic groups as for phosphomonoester hydrolysis.(69) This would leave behind the
monomeric forms that are routinely observed.
When crystallized in the presence of vanadate, all three YopH mutants (W354F,
W354H, and W354Y) show the presence of a dimeric form of vanadate. Kinetic and
crystallographic evidence is consistent with the WPD-loop impaired such that the general
acid D356 does not reach the active site. In contrast, the analogous W354F mutant of
PTP1B remains fully functional(17) and crystals grown in the presence of vanadate show
the monomeric form at the active site.(70) This is not surprising, since a functional general
acid would catalyze the decomposition by hydrolysis of the dimeric forms observed in the
loop-compromised mutants. The loss of general acid catalysis permits the trapping of a
form of vanadate that is known to exist in solution, and which the structures demonstrate
is clearly able to bind effectively to the active site. Thus, the monomeric form of vanadate
typically observed in crystal structures of phosphatases is not the only form, and may not
be the major form, that binds to the active site in solution. Phosphatase complexes with
vanadate are typically grown under conditions where oligomeric forms of vanadate
predominate. These results indicate that inhibition by monomeric vanadate is probably not
the only contributor to the biological effects of vanadate via enzyme inhibition.
The importance of local medium effects in stabilizing particular vanadate species
is another important consideration.(19, 20) These factors likely contribute to the formation
and observation of the divanadate-glycerol ester observed in the crystal structures of the
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W354H and W354Y mutants.

Glycerol is added after crystals had grown as a

cryoprotection for data collection at cryogenic temperatures (100K). Vanadate is known
to form esters with hydroxyl-bearing molecules in solution. A number of small molecule
divanadate esters are known from the Cambridge database that are analogous to the
glycerol esters found in this study, showing that such species can form in solution
independently of an enzymatic active site. Kinetic data show no indication of a synergistic
inhibitory effect on YopH activity between glycerol and vanadate. Therefore, the esters
observed in the crystals most likely formed at the active site where divanadate was already
bound. Two of the small molecule precedents for analogous polyhydroxy esters with
bridged vanadium (V) species, compound 1 (Figure 2-5D and Figure 2-S1)(71) and
compound 2 (Figure 2-S2)(53) were used in a computational analysis to assess how the
protein environment affects the bonding and charges.
Electronic nature of the divanadate complexes
Among vanadate-phosphatase X-ray structures, divanadate is uniquely found in the
W354 mutations of YopH. The local environment can significantly affect the bonding and
stability of vanadate species.(19, 20) The active site of the phosphatase VHZ allowed
stabilization and identification of metavanadate.(69)

This led to a computational

investigation of the bonding interactions within this ligand and how it interacts with the
active. The structures of the divanadate moieties are very similar in structure, but one
significant difference noted between the atomic charges of the simple divanadate complex
in W354F and the glycerol ester in W354Y is the more negative charge on the cysteine
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Figure 2-7: A stereo figure of the superposition of the YopH W354Y mutant with
published structures, comparing the position of the tyrosine side chain with
phenylalanine and tryptophan. (A) W354Y (cyan) overlaid with the W354F structure
(gray, PDB ID 3F9B). The tyrosine side chain occupies the same position as
phenylalanine. (B) W354Y (cyan) overlaid with WT YopH in the loop-open position
(black, PDB ID 1YPT). The tyrosine is coplanar with the indole side chain of tryptophan.

sulfur atom in W354F. In both complexes the sulfur is an apical ligand to the vanadium
atom at the bottom of the active site. The higher negative charge in W354F means this
interaction is more ionic in character. Similarly, both of the bridging oxygen atoms O3
and O4 are more negative in this complex. This is possibly a stabilizing response to the
larger negative charge on sulfur, as O3 is coordinated to two backbone amide hydrogen
atoms. The coordinated glycerol has the effect of reducing the polarization of these atoms.
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A gap in electron density is evident between O7 and V2 of the glycerol complex.
The computational analysis shows that this bond is highly ionic with 17% of electron
density residing on V2 and 83% on O7. In all circumstances, a bond was found between
the O7 and terminal glycerol carbon, irrespective of basis set, with high population.
The effectiveness of hydrogen bonding in the protein environment in stabilizing
charge can be seen in the comparative partial charges on oxygens O5 and O6 in the
divanadate glycerol complex. The charge is higher on the atom modeled as protonated
(O5) than on O6, which is hydrogen bonded to two backbone amide hydrogens. The small
molecule analogues were found to be very similar to their protein bound counterparts. In
particular, the partial charges on the vanadium atoms closely resembled the model with the
similar set of coordinated atoms. The vanadium atom coordinated to cysteine, V1, in both
complexes has an atomic charge very similar to that of the symmetric model compound 1,
in which each vanadium atom has four oxygens and one sulfur ligand. The outer vanadium
atom V2 has a higher partial positive charge, very similar to those in the compound 2
complex that has five oxygen ligands to each vanadium atom.
Origins of impaired loop motion by conservative mutations to Trp 354 in YopH.
Mutation of the conserved tryptophan to phenylalanine disables general acid
catalysis in YopH, but not PTP1B.(17) An examination of crystal structures reveals that,
in both enzymes, loop closure is accompanied by a repositioning of the conserved indole
side chain within a hydrophobic pocket.(18) In the complex with vanadate the W179F
mutant of PTP1B has the WPD loop in its normal closed position, and the ligand free
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enzyme has an open WPD loop. In contrast, structures of the W354F YopH mutant show
the WPD loop in the same quasi-open position regardless of whether or not an oxyanion is
bound. It was proposed that the W354F mutation locked the WPD loop in YopH, resulting
from steric clashes that would arise in a fully closed-loop conformation. The loop may not
be locked in solution. The original mutation, as well as the mutations to His and Tyr
reported here, may instead alter the energy landscape such that the quasi-open positions

Figure 2-8: A comparison of the position of the side chains of YopH W354H (Green)
and W354Y (Cyan), with the native YopH W354 (White) in the loop-closed position.
The indole N-H of the native enzyme forms a hydrogen bond with the backbone carbonyl
of T358 in the loop-closed conformation. The histidine imidazole ring in W354H
superimposes well with the indole ring of the tryptophan when the native enzyme is in the
loop- open position. A hydrogen bond is evident between the N-H of the imidazole ring
and the backbone carbonyl of the general acid P355, stabilizing the quasi-open
conformation of this mutant. No such interaction is present in native YopH. In both
structures the backbone carbonyl of residue 354 hydrogen bonds to the side chain of P355.
Upon loop closure in native YopH, this interaction is replaced by a hydrogen bond to the
N-H of R409.

54

observed are the lowest energy conformations and thus observed in crystals. There may be
further loop motion retained in solution. However, the kinetic results make it clear that
general acid catalysis is no longer operative in these mutants. If the loop is still able to
close normally, it occurs too infrequently to contribute to catalysis. The absence of acid
catalysis is inferred from loss of the basic limb of the pH-rate profile, and confirmed using
kinetic isotope effects in the original W354F mutant. 21

angles

W354F

W354H

difference

O3-V2-O5

69.4

94.4

-25

O5-V2-O6

103.5

105.1

-1.6

O5-V2-O7

129.5

89.9

39.6

O3-V2-O6

106.2

108.5

-2.3

O4-V2-O6

101.1

104.5

-3.4

O4-V2-O7

67.2

79.3

-12.1

O6-V2-O7

101.4

106.2

-4.8

Table 2-2: A comparison of the angle of the oxygen bonds around the second vanadium

in the divanadate structure and the divanadate glycerol structure. On the right are the
overlaid structures of the divanadate complexes shown in Figure 2-4A (W354Y, red) and
2-4B (W354F, cyan)
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Parameter
Q(V1)
Q(V2)
Q(O3)
Q(O4)
Q(S)
V1-S σ
V1-S π
V1-O3 σ
V1-O3 π
V1-O4
V2-O3 σ
V2-O3 π
V2-O4
LP1(O3)
LP2(O3)
LP1(O4)
LP2(O4)
LP3(O4)
LP4(O4)
LP1(S)
LP2(S)

W354Y
W354Y
(prot O5)
(prot O6)
0.47465
0.48708
0.76664
0.75449
-0.58994
-0.58636
-0.50702
-0.52930
-0.08888
-0.12353
Bond Population (|e|)
1.83403
1.87050
1.88443
none
1.82461
1.86361
none
none
1.87661
1.91441
1.87459
1.87481
1.81815
none
1.89713
1.89748
Lone Pair Populations (|e|)
1.80911
1.82386
none
1.67226
1.86524
1.85103
none
none
none
none
none
none
1.93562
1.93217
none
1.80825

W354F
(prot O5)
0.53678
0.67021
-0.71285
-0.57151
-0.32647
1.92570
none
1.94333
1.84156
none
1.88011
none
none
1.84984
none
1.82748
1.69656
1.58339
1.45719
1.95739
1.88237

Table 2-3: Electronic structure parameters characterizing the vanadium and the core
oxygen atoms of the vanadate complexes shown in Figures 4A and 4B. Structure 4A
is a glycerol ester, while 4B is only the divanadate core. The identity of the protonated
oxygen atom is given in the top row. Calculated with NBO analysis showing atomic
charges (Q) and electronic populations of 2 center-2 electron bonds and lone pairs. A
complete table including results for all the oxygen atoms appears in Supporting
Information.
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Structures of the W354Y and W354H mutants were examined for the origins of
hindered loop closure. Figure 2-7 shows the relative positioning of the Y354 side chain
compared with the F354 mutant. Both mutants have WPD-loops in similar positions, and
the residue 354 side chains are in the same positions. The lower panel of Figure 2-7 shows
an overlay of W354Y with the loop-open conformation of native YopH. Figure 2-8 shows
the YopH in the loop-closed conformation superimposed with the W354Y and W354H
mutants. In the quasi-open conformations of the mutants, the backbone carbonyl oxygen
of residue 354 makes a hydrogen bond to the side chain of the general acid D356. Upon
loop closure in the native enzyme, this interaction is replaced with a hydrogen bond to an
N-H of R409. The loop-closed conformation of the native enzyme is also stabilized by a
hydrogen bond between the indole N-H and the backbone carbonyl of T358 None of the
mutants can form this hydrogen bond.
Figure 2-9 shows a hypothetical position of the Y354 side chain in a loop-closed
position of the enzyme. This orientation was obtained by assuming the same position of
the backbone carbon chain and the first two carbons of the side chain, and co-planarity of
the aromatic rings. The hydrogens of the 6-membered ring would result in steric clashes
in a fully closed loop position. In addition, this conformation would place the phenolic
oxygen atom 1.9 Å from the backbone carbonyl oxygen of T358. Both considerations
would make it energetically unfavorable for the loop in W354Y to close in the manner seen
in the native enzyme.

57

Figure 2-9: Full loop closure of the W354Y mutant would result in several steric
clashes. The upper panel shows a space-filling model of the WPD-loop closed native
YopH. The indole N-H of the native enzyme forms a hydrogen bond with the backbone
carbonyl of T358. The lower panel shows the predicted position of the W354Y side chain
(gray) in the loop-closed position, assuming the residue backbone and the first two carbons
of the side chain occupy the same positions as W354 of the native enzyme, in purple. In
addition to significant overlap involving carbon atoms on the 6-membered ring, the
phenolic oxygen would be ~ 1.9 Å away from the backbone carbonyl oxygen of T358.

The phenylalanine and tyrosine mutants both place a six-membered ring in a
position overlaying the five-membered indole ring of the native enzyme. The histidine
mutant also exhibits a quasi-open loop, even though structural data show the fivemembered imidazole ring superimposes well with the five-membered ring of indole in the
loop-open position. However, the different regiochemistry of the N-H of the imidazole
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results in a hydrogen bond with the backbone carbonyl of P355. There is no analogous
hydrogen bond in the native enzyme, with the closest analogy being the previously
mentioned indole N-H hydrogen bond with T358 present in the closed conformation. This
interaction will stabilize the quasi-open position and present a barrier to full loop closure.

Conclusions
The rates of WPD-loop movement have been shown to be variable among PTP
family members, and are correlated with their catalytic activities. Conservative mutations
to noncatalytic residues in the loop have different effects in YopH compared to PTP1B.
The present results show that YopH is intolerant of any aromatic side chain in the 354
position other than the indole found in the native enzyme. In all three mutants with other
aromatic side chains, in crystal structures with vanadate bound the WPD-loop is found in
a similar, quasi-open position that does not permit acid catalysis.
The results show that, unlike PTP1B, YopH is completely intolerant of even
conservative substitutions to the tryptophan side chain in the WPD-loop. The vanadatecomplexed structures provide further support, beyond the single previous instance, for the
ability of divanadate to bind to the active site of PTPs. Although crystal structures of
vanadate bound to native phosphatases show only the monomeric form, vanadate has
significant biological effects and is a potent phosphatase inhibitor under conditions where
oligomeric forms are dominant. The consistent finding of a dimeric form in all three WPDloop compromised YopH mutants shows the single previous instance was not an anomaly,
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and suggests that oligomeric forms of vanadate and their esters can compete for PTP active
sites. More hydrogen bonds are observed with the divanadate species than the monomer.
A native PTP would cleave such forms, leaving behind the monomeric vanadate typically
observed. The initial binding of higher order vanadate oligomers to phosphatases likely
contributes to their inhibitory activity, before they are hydrolyzed to the monomeric form
observed in crystal structures.
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CHAPTER 3
YOPH AND PTP1B CHIMERAS SHOW THE IMPORTANCE OF THE WPD-LOOP
SEQUENCE TO THE CATALYTIC ACTIVITY OF PTPs

Introduction
Protein phosphorylation plays a critical role in many eukaryotic cellular processes.
The modification of proteins via phosphorylation is the most common post translational
modification

(1,

2).

Unlike

many

biological

enzymatic

reactions,

the

phosphorylation/dephosphorylation cycle is not reversible by the same enzyme. Protein
kinases phosphorylate the protein while protein phosphatases dephosphorylate them.
Because of this, protein kinases and phosphatases have been called the Yin and Yang of
signaling in the cell(3).
Our research in the Hengge lab has focused on protein tyrosine phosphatases
(PTPs), particularly their catalytic mechanisms, as PTPs are among the most effective
enzymes known. Previous results showed there is a correlation between the WPD loop
movement and the catalytic rates of the PTPs PTP1B and YopH. Subsequent research
directed toward understanding the factors that control WPD-loop dynamic rates has
explored several areas (Figure 3-1). In one, endeavors into locking the WPD loop in the
catalytically active, closed position through single point mutations in YopH left the WPD
loop in a quasi-open, non-catalytically active position, as described in the previous chapter
two(4). Therefore, other methods are needed to understand the factors that affect WPD
loop
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Figure 3-1. Orientation of key residues at the active site of PTP1B (green) and YopH
(gray). Structures were aligned to give the best overlap of the P-loop backbones, which
extend from the cysteine to arginine residues. (A) Superimposition of the vanadate-bound
structures with WPD-loop in the open conformation, using the same orientation as in (B).
(B) Superimposition of the apo structures with the WPD-loop in the closed conformation.
The lower, italicized residue numbers refer to YopH. Side chains are shown for the
numbered Cys, Arg and Asp residues but for the sake of clarity only the backbone carbonyl
group of W179/W354 is shown. Hydrogen bonds in dotted blue lines are shown only for
YopH. The PDB IDs used to generate each structure were: PTP1B wildtype: 2CM2 (apo
form, open WPD-loop, and 3I80 (VO4 bound, closed WPD-loop; YopH wildtype: 1YPT
(apo form, open WPD-loop) and 2I42 (VO4 bound, closed WPD-loop).

mobility, and how that affects the catalytic rate. Sequence comparisons of the residues in
the mobile WPD loops within the PTP family show that only the WPD residues are highly
conserved, while the rest of the residues are partially conserved or not at all conserved
(Figure 3-2). A chimera was designed with the WPD loop of PTP1B spliced into YopH,
replacing its WPD-loop. The original chimera (1) swapped region was the chain of WPD
loop residues from the end of the beta sheet to the start of the alpha helix as seen in the
published crystal structures. Supposing that the WPD loop sequence determined the rate of
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the WPD loop movement, then, WPD-loop motions and the catalytic rate in this new
chimera should be similar to those of PTP1B.

Dynamic
loops
Static loop
loops

Figure 3-2: A comparison of the WPD loop conservation across the PTP family. The
acid-loop regions of several PTPs, including three PTPs with immobile IPD general acid
loops (SsoPTP, VHZ, and TkPTP). YopH had the most unique sequence of all the WPD
loops and is also the fastest. Intensity of red color indicates the degree of conservation.

Experimental Procedure (Material and Methods)
Chemicals
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DTT and AMP were purchased from GoldBio. All other buffers and reagents were
purchased from Sigma-Aldrich or Fisher. p-NPP was made and purified as previously
described(5).

Crystallography screens, trays and cover slips were purchased from

Hampton research.
Protein Expression and Purification
The YopH chimera (1) DNA was made by the Loria lab and was sent to the Hengge
lab for kinetic analysis. The subsequent mutations for the YopH chimera were performed
here, using the Q5 Site-Directed Mutagenesis Kit. The primers were designed using the
NEBbasechanger website recommended by the kit (Table 3-2). The WPD-loop region that
shows the WPD-loop swapped out with the PTP1B WPD-loop is seen (Figure 3-1).
The procedure for expression of the original YopH chimera and all mutants was as
follows: the DNA was transformed into BL21 codon plus cells and let grow over night on
a LB culture plate with AMP at 37ºC. One colony on the plate was placed into 5mL of LB
media containing AMP and let grow overnight. In the morning, 1L of LB media with 100
ug/mL AMP was inoculated with the 5mL growth and shaken at 180 RPM and 37°C for
about 5 hours until the OD600 reached 1.0. The 1L growths were then induced with 100mg
of IPTG and moved to a room temperature shaker and shaken at 180 RPM overnight. The
cells were then harvested by centrifugation at 8K RPM for 15 minutes at 4C and stored in
the -80C freezer(6).
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Table 3-1: List of YopH Chimera 2 primers used to make the mutation that lead
to the discovery of YopH chimera 3.
Name of primer

Oligo (Uppercase = target-specific primer)

E361S_Forward

TGGAGTCCCTagtTCAGAAGTTACCAAG

E361S_Reverse

AAGTCAGGCCATGTGGTAAC

P360V_E361S_Forward

CTTTGGAGTCgtcagtTCAGAAGTTACCAAGGCAC

P360V_E361S_Reverse

TCAGGCCATGTGGTAACATG

E363P_Forward

CCCTGAATCAccAGTTACCAAGGCACTC

E363P_Reverse

ACTCCAAAGTCAGGCCATG

E361S_E363P_Forward

caccAGTTACCAAGGCACTCGC

E361S_E363P_Reverse

aactAGGGACTCCAAAGTCAGG

The cells were removed from the freezer and kept on ice at 4C during lysis. The
cells were resuspended in the lysis buffer, 100 mM MES, 1 mM DTT, 1 mM EDTA, 10%
Glycerol, pH 5.7, and one EDTA-free protease inhibitor cocktail tablet for every 50 mL.
The cells were lysed via sonication in a metal beaker at 60% power and 60% pulse for 15
pulses then stirred on ice for 1 minute, this was repeated 8 times. The lysate was then
centrifuged for 50 minutes at 18K RPM at 4C. The supernatant was collected and filtered
with a 0.65uM syringe filter. The filtrate was then loaded into the super-loop to be loaded
on to the columns. The Q-column and S-column were hooked up to the FPLC machine in
that order and washed with 2M NaCl until the absorbance at 280nm dropped and the
conductivity was level. The columns were then equilibrated with buffer A, 100mM NaAc,
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1 mM DTT, 1 mM EDTA, 10% Glycerol, pH 5.5, and pump 2 was primed with buffer B,
100mM NaAc, 500mM NaCl, 3 mM DTT, 1 mM EDTA, 10% Glycerol, pH 5.5. The
columns were then loaded via the super-loop at a rate of 1mL per minute.
After loading was complete the Q-column was removed and 10ml of buffer A was
washed over the S-column. Then a 150mL gradient was started to elute the protein from
the column. Finally, the column was washed with 10ml of buffer B then 10 mL of buffer
A. The fractions of 150 mL gradient that show UV absorbance at 280nM were activity
tested by mixing 50uL 40mM p-NPP, 100uL buffer and 100uL from each fraction. The
fractions showing activity were also run on a 12% SDS page gel to test for purity and to
make sure the isolated protein is the correct weight. If the protein is impure the fractions
were concentrated to 10mL total volume and run over a 360ml superdex column, using the
following buffer, 100mM NaAc, 100mM NaCl, 3 mM DTT, 1 mM EDTA, pH 5.5. The
correct peak was identified by another 12% SDS gel and the fractions where then pooled
together. The protein was then concentrated to around 1-5 mg/mL, diuted with 15%
glycerol and either frozen at -80ºC for kinetics or further concentrated to 15-20 mg/mL for
crystal trays that were set up within 72 hours after the purification.
Crystallography
For the crystallization conditions of YopH chimera 2, hand trays were set up with
many different conditions but, the ones that had crystals in them that gave the best
resolution were (Table 3-2), was a hand tray using hanging drop diffusion with 0.1 M
HEPES at pH 7.5 and PEG 3350 to make a total of 1000µl of well solution. For the apo
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crystal structure the enzyme was concentrated to 15 mg/mL. The well solution was 0.1 M
HEPES at pH 7.5 and 18% PEG 3350. The drop was made up of 3µL of well solution, 0.5
µL seeding at 100X dilution of previous apo YopH chimera 2 crystals and 2µL of enzyme
(in the original buffer solution of 100mM sodium acetate, 100mM NaCl, 1 mM EDTA,
and 1 mM DTT at pH5.5).
The formed crystals were then prepared for flash freezing with liquid nitrogen by
transferring them into a stabilization solution that increased the concentration of glycerol.
The first solution was the same as the well conditions with 0% glycerol. The glycerol was
increased in 5% increments until the final solution was at a total of 20% glycerol. The
crystal was carefully transferred into each condition and allowed to acclimate for 5
minutes. Then the crystal was flash frozen in liquid nitrogen and stored under liquid
nitrogen until X-rayed.
For the YopH chimera 2 vanadate bound structure, enzyme was co-crystallized with
vanadate at 5 times the enzyme concentration using hanging drop diffusion with 0.1 M
HEPES at pH 7.5 and 14% peg 3350 to make a total of 1000µl of well solution. For the cocrystallization the enzyme consentrated to 12.3 mg/mL is mixed with the sodium
metavanadate (Na3VO4) at a 1:5 molar ratio and let sit on ice for 30 minutes before the
mixture is added to the drop. Each drop was made up of 3µL of well solution and 2µL of
enzyme with inhibitor mixture. A stock solution of Na3VO4 was made up to a concentration
of 106.4mM in dilute NaOH to keep the vanadate from polymerizing in solution(7). The
solution of sodium metavanadate concentration was checked by UV spectroscopy at 260
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nm. The crystal were prepared for cryo-cooling in the same way as the apo crystals and
then flash frozen with liquid nitrogen.
For all the YopH chimera 3 crystals structures solved came from apo crystals and
the ligands were soaked into the already formed crystals. The crystals were grown in hand
tray using hanging drop diffusion with 0.1 M HEPES at pH 7.5 and 24% peg 3350 to make
a total of 1000µl of well solution. The enzyme was concentrated to 18.77mg/mL in the
original buffer solution of 100mM sodium acetate, 100mM NaCl, 1 mM EDTA, and 1 mM
DTT at pH5.5. Each drop was made up of 3µL of well solution and 2µL of enzyme. The
crystals where then prepared for cryo-cooling in the same way as the apo crystals of YopH
chimera 2 were prepared but before flash freezing with liquid nitrogen a soak was made up
using the same stock solution of sodium metavanadate as the YopH chimera 2. For the
vanadate crystal structure the sodium metavanadate was at a concentration of 10mM. For
crystal structure a solution was made with the sodium tungstate at a concentration of
10mM. The crystals were soaked for 30 minutes before they were flash frozen in liquid
nitrogen.
Data collection and validation
Crystals were screened on a home source X-ray system, and diffraction data were
collected at the Stanford Radiation Lightsource (SSRL). The molecular replacement was
performed with Phaser(8) through the phoenix sweet using YopH W354Y (PDB ID 4YAA)
as the search model because it is the best resolution structure available at 1.05Å. Model
building, refinements and validation was performed using Phoenix(9) (10), Coot (11) and
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Table 3-2: X-ray crystallography data collection and refinement statistics.
Chimera 2
apo

Chimera 2
VO4

Chimera 3 apo

Chimera 3
VO4

Chimera 3
WO4

SSRL I4

SSRL H8

SSRL F5

Home source
Recollected SSRL
D2

SSRL G1

Data location

Data collection
Source
Space group
Cell dimensions
a, b, c (Å)
   ()
Resolution (Å)
CC1/2
I / I
Completeness
(%)
Redundancy
Refinement
No. reflections
Rwork / Rfree
No. atoms
Protein
Ligand/ion
Water
B-factors
Protein
Ligand/ion
Solvent
R.m.s deviations
Bond lengths
(Å)
Bond angles
()
Ramachandran
Favored (%)
Allowed (%)
Outliers (%)

SSRL 14-1
P212121

P212121

P212121

SSRL 14-1
P212121

SSRL 14-1
P212121

51.1, 53.2,
95.7
90.0, 90.0,
90.0
50-2.50
(2.59-2.50)
0.507
7.3 (1.1)
99.7 (97.4)

49.7, 54.7,
96.5
90.0, 90.0,
90.0
50-1.83
(1.92-1.85)
0.607
15.1 (1.6)
100.0 (100.0)

49.8, 53.8,
103.2
90.0, 90.0,
90.0
50-1.95 (2.021.95)
0.606
14.4 (1.4)
95.6 (92.1)

49.1, 54.8,
96.8
90.0, 90.0,
90.0
50-2.10
(2.18-2.10)
0.569
15.9 (1.6)
99.6 (99.8)

49.7, 54.9,
97.8
90.0, 90.0,
90.0
50-2.75
(2.85-2.75)
0.602
23.0 (1.5)
99.9 (100.0)

9.6 (8.5)

9.2 (9.1)

12.6 (12.5)

4.7 (4.4)

9.5 (9.3)

9,549 (908)

20,058 (1866)

15,695 (1490)

7,383 (682)

0.217/0.255

23,165
(2,250)
0.173/0.209

0.176/0.217

0.174/0.226

0.213/0.264

2171
0
71

2185
12
161

2140
0
226

2172
5
105

2142
5
0

40.8
38.0

31.9
46.5
39.0

27.8
37.8

42.2
60.6
47.3

74.8
107.4
-

0.002

0.006

0.003

0.008

0.002

0.514

0.793

0.616

0.876

0.474

97.5
2.1
0.4

97.5
2.1
0.4

97.1
2.5
0.4

97.1
2.5
0.4

96.4
3.2
0.4
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Molprobity(12). All figures of the enzyme structure and structure alignments there n were
made using Pymol(13).

Kinetics
Kinetics for all chimeras were run at room temperature (23ºC). The concentrated
stock enzyme was slowly cooled on ice and diluted with water, then diluted with buffer
base mix (100mM sodium acetate, 100mM Tris, 100mM and Bis-Tris) at the appropriate
pH. The substrate para-nitrophenylphosphate (p-NPP) was synthesized as previously
stated and then recrystallized in ethanol with cyclohexylamine to form the
dicyclohexylammonium salt(5). A stock solution of the substrate, pNPP, was dissolved in
buffer base mix to a concentration of 40 mM and then the pH was checked and adjusted by
titration with acid or base.
End point kinetics were run using a 96 well plate by mixing different amounts of
buffer with the same pH p-NPP solution. Substrate concentration ranged from 0.25-25 mM
p-NPP. The diluted enzyme was then added to the wells and, after a period of time ranging
from 5-30 minutes, the solution was quenched with 10N sodium hydroxide, which stopped
the reaction and brought the pH above 9 so that all of the hydrolyzed 4-nitrophenol was in
the ionic form. Only the product, 4-nitrophenol, was ionized, giving the compound a yellow
color with an extinction coefficient of 18000M-1cm-1 at 400nM at which point a reading of
the absorbance for each well was taken. A blank was also made with the same concentration
of substrate for each well and instead of enzyme, more buffer was added and was also
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quenched with 10N NaOH. The absorbance for each well was then taken and the blank
well was subtracted from the absorbance of the well for the kinetics run to give the total
absorbance produced by p-nitrophenol product formed by the enzyme. The corrected
absorbance was converted to concentration using the Beer-Lambert Law, where A is the
absorbance, ɛ is the extinction coefficient, l is the path length traveled, and c is the
concentration Equation 1. The points were then fit to the Michaelis-Menten equation where

v is the rate in µM/s-1 (unless otherwise stated), and S is the substrate concentration.
A=ɛlc

Equation 1

v = Vmax[S] / (KM + [S])

Equation 2

Kinetic Isotope effects, (KIEs) for YopH chimera 3 were measured including 15N,
18

O bridging and 18O nonbridging as described in chapter 1. The specific for YopH chimera

3 KIE are as followed. The 15N KIE was measured first, using the natural abundance 15N
concentrations in p-NPP. The substrate p-NPP was dissolved in buffer base mix pH 5.5 at
room temperature to a concentration of 8-12 mM. The enzyme was added for a final
concentration of 0.134 µM, and the reaction was allowed to run until 40-60% of the
substrate was hydrolyzed. The completion of the reaction was measured by UV-Vis
spectroscopy at 400nM. The product was extracted with diethyl ether and purified via
sublimation and deposition of the pure product. The residual substrate was hydrolyzed with
alkaline phosphatase overnight. The nitrophenol released from the residual substrate was
then extracted with diethyl ether and also purified via sublimation and deposition of the
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pure product. Three repetitions of each isotope effect experiment were carried out, and 1
mg of p-nitrophenol from each from the samples were prepared and sent for analysis by
isotope ratio mass spectrometry, IRMS. The KIE for the bridging and nonbridging
positions were taken and measured in the same way.

Results and discussion
The protein expressed from the original YopH chimera 1 DNA was insoluble, so
the area of the WPD loop swapped region in crystal structures was reexamined (Figure 33). In the chimera 1 the V351Y mutation seemed to be the issue. In PTP1P the tyrosine
residue in this position makes a hydrogen bond with a serine on the alpha helix adjacent to
the WPD loop. In contrast, in YopH, the corresponding residues are both hydrophobic
valines (Figure 3-4). The introduction in the YopH chimera 1 of a tyrosine residue in this
position most likely caused the aggregation or misfolding issues. Therefore, in chimera 2
the Y351 was mutated back to valine. The YopH chimera 2 protein expressed and purified
similar to YopH WT protein, however, the kinetics showed that it was over 1000-fold
slower than the wild type (Figure 3-6). Furthermore, the pH dependency was lost,
indicating failure of general acid catalysis.
A crystal structure of chimera 2 was obtained, which shed light into the cause of
the poor catalytic function. The first crystal structure that was solved was co-crystalized
with vanadate (Figure 3-7). This showed the vanadate in the active site at high resolution
2.2Å. From the kinetic results we knew that this mutation was minimally active, but the
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structure showed the reasons why. The P-loop and vanadate were in the expected place but
the WPD-loop was in a completely novel position. The vanadate bound to the active site
should have favored the closed WPD loop position, but in this structure, it was not. In
native YopH, the WPD-loop starts at the end of a beta sheet and ends at the start of an alpha
helix.
When the loop region was in the closed position, the alpha carbons of W354 and
S361 were 7.2Å apart and the loop was 10.1Å long. In contrast, the WPD-loop of the YopH
chimera 2 the alpha helix at the end of the loop was extended, which pulled the rest of the

#349

#368

Figure 3-3: YopH PTP1B chimera swapped region was shortened to improve overall
structure and catalytic activity. In order to probe how the WPD-loop sequence and rate
of closure affect catalysis, the PTP1B WPD-loop was swapped into YopH. The original
chimera 1 was made by swapping all of the residues in YopH that were assigned to the
mobile loop, based on examination of crystal structures, and not part of the beta sheet
before the WPD-loop or the alpha helix at the end. The bold letters are the sequence of
amino acids comprising the WPD-loop in YopH. The italic letters are the sequence
comprising the WPD-loop in PTP1B. Three chimeras were made with different lengths of
swapped WPD-loop regions in order to find the most active chimera.
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WPD loop out of the active site. The general acid D356 backbone moved 5.9Å from the
closed to open positions in the native protein. In the YopH chimera 2 extended alpha helix
structure, the general acid D356 backbone was 7.9Å distant from the open position and
10.6Å from the normal closed position (Figure 3-5). This leaves the general acid in a
position too far away to function in the mechanism, which was reflected in the kinetic data.

Figure 3-4: At the ends of the WPD loop in PTP1B there is a hydrogen bond, but in
YopH there are only hydrophobic residues, thus when only one of the residues was
swapped, the resulting protein was insoluble, presumably due to misfolding. This
hydrogen bond is formed between tyrosine 176 and serine 190 in PTP1B is shown in green
(PDB ID 5KA3). In YopH, the corresponding residues are hydrophobic, valine 351 and
valine 364, shown in black (PDB ID 3BLU). When the tyrosine residue was swapped into
the YopH, in chimera 1 the clash from the hydrophobic and hydrophilic residues caused
the protein to misfold and become insoluble.
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With this information, once again the area of the WPD loop swapped region was
reexamined, particularly focusing on the residues 359-364 that make up the extended alpha
helix. In both PTP1B and in YopH a serine (S) is in position 362 (Figure 3-5). In YopH it
is the start of the alpha helix, while in PTP1B, the next residue is a proline (P) and it starts
the alpha helix. Because prolines have the 5-membered ring that includes the backbone
carbons, its range of rotation is very limited. Therefore, the first mutation that was tried
was to extend the swapped region by one residue via the mutation E363P. It was hoped this
mutation would force the backbone into a more productive position and proline residues
are normally found at the beginning or inside of alpha helixes, but not in loop or very
mobile regions. The goal of this change was to have the alpha helix start in the same place
as in native PTP1B. This mutant enzyme purified similarly to YopH WT with good yields,
but the kinetics showed a kcat of <1s-1 at pH 5.5, very similar to that of YopH chimera 2
(Table 3-3).

Table 3-3: List of all the mutants made and
kinetically characterized from YopH chimera 2
Mutation(s)

kcat s-1

E363P

0.0288

E361S

0.033

E363P and E361S

0.059

E361S and P360V

5.1
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Table 3-4: List of PTP with their kinetic parameters and conditions, showing that
YopH chimera 3 (YChi3) kcat, while slower than YopH or PTP1B it is on par with
the rest of the family (14).
Enzymes

kcat(s−1)

Km(mM)

kcat/Km(s−1·mM−1)

Conditions

YOPH

1234

2.40

514

pH 5.0, 100 mM acetate, 150
mM NaCl, 30°C

SH-PTP1

155

148

1.0

pH 5.5, 100 mM MES, 150
mM NaCl, 10 mM DTT, 1 mM
EDTA, 23°C

PTP1B

48

0.23

209

pH 5.0, 100 mM acetate, 150
mM NaCl, 30°C

rIAR

6.1

0.42

14.5

pH 5.0, 40 mM MES, 30°C

VHR

5.14

1.59

3.24

pH 6.0, 100 mM acetate, 50
mM Tris, 50 mM Bis-Tris,
30°C

YChi3

5.1

5.69

0.90

pH 5.5, 100 mM acetate, 50
mM Tris, 50 mM Bis-Tris,
23°C

LARD1

4.1

1.73

2.37

pH 6.0, 100 mM MES, 25°C

VHR

3.65

7.99

0.457

pH 7.0, 100 mM acetate, 50
mM Tris, 50 mM Bis-Tris,
30°C

YPTPl

1.6

1.18

1.36

pH 5.5, 100 mM acetate, 150
mM NaCl, 30°C

VH1

0.3

7.7

0.039

pH 5.5, 100 mM acetate, 150
mM NaCl, 25°C

Cdc25

0.033

50

0.00066

pH 8.2, 100 mM Tris, 250 mM
NaCl, 37°C

0.013

pH 5.6, 50 mM 3,3dimethlyglutarate, 50 mM
NaCl, 10 mM DTT, 2 mM
EDTA, 24°C

SH-PTP2

0.046

3.6
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The next position in the YopH chimera 2 that was examined was E361. In YopH
chimera 2 the side chain of the glutamic acid E361 is pointing towards the active site, while
in PTP1B it is pointing away and the backbone is 3.3Å farther from the active site. In YopH
there is a serine with its backbone in the same position, but the smaller side chain is again
facing away from the active site and resides over the alpha helix. Thus, the mutant E361S
of YopH chimera 2 was made and purified similarly to YopH WT with good yields, but
the kinetics showed a kcat of <1s-1 at pH 5.5, again similar to the YopH chimera 2 (Table
3-3).
The next position mutation that was tried was a combination of the both E361S
and E363P in the YopH chimera 2. This mutation would allow the alpha helix to start at
position P363 and have a smaller side chain residue at the top of the alpha helix. But again,
YopH chimera 2 E361S and E363P was made and purified similarly to YopH WT with
good yields, but the kinetics still showed a kcat of <1s-1 at pH 5.5 (Table 3-3).
The last position that was examined was P360. The YopH chimera 2 has the V359
as the start of the alpha helix but the next residue is a proline. This prolines’ P360 alpha
carbon is 6.4Å away from the alpha carbon of PTP1B proline. As mentioned before,
prolines’ restricted range of motion helped to stabilized alpha helixes, so replacing P360
with valine could restore the WPD loop length. This would shorten the swapped region by
two residues, and so, the mutant E361S DNA was taken and primers were designed to keep
the E361S mutation in while also incorporating the P360V mutation. This mutation worked
and the protein showed high kinetic activity! Therefore, this protein was designated YopH
chimera 3, whose swapped region was shortened by two residues P360V and E361S
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10.6Å
P360
P185

V360

A

E186

B

P188

E361

S361

C

E363
E363

D

Figure 3-5: The extended alpha helix region residues in YopH chimera 2, compared
to YopH Wt and PTP1B Wt all with ligands (VO4) bound in the active site, causing
the WPD loop to be in the closed position. This novel extended alpha helix formation
explained why YopH chimera 2 is so slow, but not why this conformation exists. Neither
Wt YopH nor PTP1B have the alpha helix starting at position 359. So an in-depth look at
the structure of the alpha helix was done and 3 key residues were identified in the YopH
chimera 2: P360, E361, and E363. The yellow line measures the distance between alpha
carbon of D356 for YopH Wt with the WPD-loop in the closed position with YopH chimera
2 D356 alpha carbon, top left A. YopH is shown in gray with residues 360-363 shown in
pink, PTP1B is shown in black with residues 360-363 shown in chocolate brown, and
YopH chimera 2 shown in blue with residues 360-363 shown in red. The P360 that is found
in PTP1B is a semi conserved residue throughout the family but YopH has a valine at that
position, top right B. The E361 is found in PTP1B while YopH has the much smaller
residue serine; both residues are represented in other members of the family, bottom left
C. The residues of the alpha helix are not conserved in the family but all participate in the
alpha helix which all starts at residue 362 ± 1. The E363 is found in YopH while in PTP1B
the residue is proline. That proline starts the alpha helix in PTP1B, is a much smaller
residue, and has a constricted backbone rotation that strengthens alpha helix formations,
bottom right D.
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compared with chimera 2 (Figure 3-2). Again, the expression and purification was very
similar to YopH WT. The kinetics were found to still be ~100-fold slower the YopH WT,
and ~10-fold slower than PTP1B. However, the YopH chimera 3 at the pH optimum had a
kcat of 5.1 s-1 which is on par with many other wild type PTPs in the family (Figure 3-6).
The pH rate profile of the PTP shows the activity of the enzyme and also what key
residues are playing a part in the mechanism as explained in the kinetics section of chapter
1 (page8-10). The bell-shaped curve for both YopH and PTP1B results from the two key
residues and their protonation states (Figure 3-6). The basic limb of the curve is made by
the deprotonation of the aspartic acid, which needs to be protonated in the first step of the
mechanism, in order to neutralize the developing oxyanion as the P-O bond is cleaved. The
acidic limb of the curve is from the nucleophilic cysteine in the active site that is negatively
charged to attack the phosphate. As the cysteine becomes protonated at lower pH the
enzyme becomes less active. Thus, the presence of the bell-shaped curve in YopH chimera
3 shows that both of these residues are part of the mechanism, and the overall mechanism
is intact. While this is good, it is a broad look at what is going on, and does not explain
why the enzyme has an overall lower rate than PTP1B and YopH.
KIE were measured to give an in depth look into the mechanism of YopH chimera
3 and to understand how the rate has been lowered while using the same mechanism. In
the WT PTPs the 15N KIE is 0.9999-1.0004, while the removal of the general acid increases
the value to 1.0024-1.0030. The 15N KIE of YopH chimera 3 is 1.0004 ± 0.0002, showing
that general acid catalysis is active and as effective as the WT PTPs. The 18O bridging KIE
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Figure 3-6: Kinetics show full restoration of mechanism, via the bell-shaped curve,
for chimera 3, but a reduced catalytic rate. The chimera 3 is active but ~100-fold slower
than YopH and ~10-fold lower than PTP1B. However, the mechanism is unchanged and,
while slower than either of its parent enzymes, is similar in rate to many native proteins in
the PTP family. In contrast, chimera 2 has lost its bell-shaped curve, and is over 1000-fold
slower. The pH rate profile of YopH Wt is shown in black, PTP1B Wt in green, YopH
chimera 2 in blue, and YopH chimera 3 in red.

for the WT PTPs is 1.0118-1.0152 while the removal of the general acid increases the value
to 1.0275-1.0297. The

18

O bridging KIE for YopH chimera 3 is 1.0197 ± 0.0010. This

value is above the WT PTPs but below the D-N mutations, showing that the general acid
is functioning to neutralize the charge build up on the bridging oxygen, but perhaps slower
than the WT PTPs. The 18O non-bridging KIE for the WT PTPs is 0.9998-1.00018 while
the removal of the general acid increases the value to 1.0019-1.0024. The 18O non-bridging
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Table 3-5: Data comparing the KIEs of Chimera 3 with those from wild type (WT)
PTPs and general acid removed mutants, which shows that chimera 3’s general acid
is functional, although at a slower turnover rate than the WT. The 15N KIE of almost
unity shows that there is no charge building up on the leaving group, therefore the general
acid is fully functional. In all of the WT PTPs this KIE is also near unity, but, the aspartic
acid D to asparagine N mutations have a normal 15N confirming the absence of the general
acid. Chimera 3’s near unity 15N KIE shows that its general acid is indeed fully functional.
The 18O bridging KIE indicate how tight or a loose the transition state is. The large KIE in
this position in the D to N mutations of close to 1.03 shows a very loose transition state
with significant P-O bond cleavage and charge build up on the phenolate leaving group.
The WT PTPs have a lower normal 18O bridging KIE due to protonation of the bridging
oxygen atom in the transition state, that indicates a loose transition state but without the
charge build up. The chimera 3 18O bridging KIE is modestly larger than the WT data but
closer to this range than to data from D to N mutants. The non-bridging KIE is within the
range of WT PTPs as well. Overall, the KIE data for Chimera 3 show a transition state not
significantly altered from that of the WT enzymes, and confirms the conclusion from the
pH-rate profile that general acid catalysis is functional.
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Figure 3-7: The extension of the α helix in the YopH Chimeras is a probable cause of
their decreased overall catalytic rates. Chimera 2’s α helix is extended and forces the
WPD loop out of the active site, disabling general acid catalysis, and causing its drastically
lower rates and absence of pH dependency. Crystal structures show that Chimera 3 can
also adopt this non-active α helix extended position, but kinetics indicate it can also adopt
a functional WPD-loop position to perform catalysis. The pictures are superimposed based
on the P-loops (not shown) and the gray scale WT open to closed WPD loop. The
superposition of the ligand-free crystal structures: YopH shown in grey PDBID: 1YPT;
PTP1B shown in dark gray PDBID: 3A5K, and ligand bound structure of PTP1B shown in
black PDBID:3I7Z. A-E all have the gray scale WT WPD-loops shown. A, YopH chimera
2 ligand free shown in blue in the extended alpha helix position. B, YopH chimera 2 with
vanadate in the active site, shown in blue; C, YopH chimera 3 ligand free, with the WPD
loop in the normal, open position shown in dark red; D, YopH chimera 3 with vanadate in
the active site, shown in red; and E, YopH chimera 3 with tungstate in the active site, shown
in pink.
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KIE for YopH chimera 3 is 1.0015 ± 0.0008. This value is in the range of the WT PTPs,
and below the D-N mutations, agreeing with the previous KIE in that the general acid is
active while the overall rate is on the slower side for a WT PTP. All the KIEs measured
on the YopH chimera 3 indicate that the general acid is active. In comparison to the
YopH WT and PTP1B the YopH chimera 3 shows more similarity to PTP1B than to
YopH (Table 3-5).
Crystal structures of chimera 2 ligand free and vanadate bound both have the
extended alpha helix. This corroborates with all of the kinetic data in that the activity has
almost completely been abolished, and the general acid is not functional. For YopH
chimera 3 there have been ligand free, vanadate bound, and tungstate bound structures
solved, thanks to the work of the Johnson lab and particularly Dr. Morales. Interestingly,
the ligand free structure has YopH chimera 3 with the WPD loop in the open position while
both the vanadate and tungstate structures have the extended alpha helix (Figure 3-7). This
shows that while the general acid is active and able to adopt a conformation in which it is
able to enter the active site, this chimera can also adopt the inactive, extended alpha helix
form. This inactive form could be the reason that YopH chimera 3 is slower in turnover
rate than both PTP1B and YopH (Figure 3-6). With part of the enzyme taking this novel
conformation the average turnover rate is slower than either parent, but is within a range
that is normal for most the enzymes in the PTP family.
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Conclusions
Creating a chimera of two different proteins is not as simple as selecting the section
to replace then cutting it into the base protein, as the construction of YopH chimera 3 has
shown us. In order to make an enzyme with PTP1B’s WPD loop and the rest being YopH,
the area of the protein that was identified as the WPD-loop in the crystal structures was
identified and swapped (Figure 3-3). This protein was insoluble due to misfolding. Closer
examination revealed that one residue capable of donating a hydrogen bond in YopH had
been replaced with a hydrophobic residue from PTP1BThis was converted back to keep
that bond hydrogen bond intact. This led to chimera 2, which, although soluble, showed
kinetic activity that was over one thousand-fold slower than either YopH or PTP1B. This
shows that every amino acid around the active site must be carefully examined for how it
interacts in 3-dimensional space with surrounding amino acids, that a single hydrogen bond
lost can cause the entire enzyme to misfold, and therefore, the importance of every
interaction no matter how small for catalytic function.
The crystal structure of YopH chimera 2 showed that the protein overall was indeed
back to the WT YopH 3D structure except for the position of the WPD-loop near the active
site. The WPD-loop was in a novel position that completely removed residue D356 from
the active site, and abolished general acid catalysis. The alpha helix at the end of the WPD
loop was extended by three residues, or a half turn of the helix. The half turn of the helix
caused the WPD-loop to end on the far side of the alpha helix that extended distance
straightened out the WPD-loop so instead of the loop arching over the active site the WPDloop stays to outer edge of the active site. There is no evidence to date that any native WT
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members of the PTP family have a similar extended alpha helix conformation, either during
or after catalysis. Both the ligand-bound and ligand-free structures show this extended
alpha helix conformation, which, taken in conjunction with the flat pH rate profile and
extremely low activity, suggest that this enzyme is most likely stuck in this unproductive
form whether or not substrate is bound. The other aspects of the active site are still intact,
with the cysteine residue in place, which make it possible for a low level of catalysis. This
change to a more open active site and elimination of the general acid mechanism hampers
catalysis so much, and removes the movement of the WPD loop that it could not be used
to probe the understanding of the dynamics in catalysis.
The swapped region of YopH chimera 2 was reexamined, and a number of
mutations were made to either shorten or lengthen the swapped region, and tested. This led
to the creation of YopH chimera 3, whose transposed WPD-loop was shorted by two
residues compared to chimera 2. YopH chimera 3 is about 2 orders of magnitude slower
than YopH, and 10-fold slower than PTP1B. The catalytic general acid activity is fully
restored, as shown by the bell shaped curve of the pH rate profile (Figure 3-6). Crystal
structures show the WPD loop can assume both the extended alpha helix position and the
normal open position. We hypothesize that the reason this chimera is slower than both
YopH and PTP1B is because the protein can form both, the extended alpha helix
conformation where catalysis is not possible, but also the normal WPD loop position that
enables general acid catalysis. For catalysis to occur the protein must first reconfigure into
the non-extended alpha helix conformation, with the general acid functioning. This extra
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step of getting into and out of this non-catalytically active form slows the overall turnover
rates that were measured.
Using the hypothesis that only a portion of the enzyme is in a catalytically
functional state at any given time, the turnover rates would be expected to be reduced. The
catalytic rate of the correctly configured protein would then be faster than the turnover rate
measured. This could be probed using single molecule kinetics. The rates of the WPD loop
movements will also help to puzzle out this mystery because, if the WPD loop motion rates
are significantly faster than the overall turnover rate, it would indicate that this inactive
form of the protein is contributing to the reduced rate.
In conclusion, the YopH chimera 3 is a fully functional PTP. While its catalytic rate
more resembles PTP1B than YopH, it is a new and different PTP. YopH chimera 3 is a
unique enzyme and has its own mechanistic timing and rates.
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CHAPTER 4
THE HYDROPHOBIC POCKET IN WHICH THE TRYPTOPHAN OF THE WPDLOOP SLIDES DURING WDP LOOP MOTION IS CRITICAL FOR CATALYSIS IN
PTPs

Introduction
Previous chapters have described research into the role of the WPD-loop in PTP
catalysis, but this chapter will focus on the role of surrounding residues, specifically those
that form a hydrophobic pocket that interacts with the side chain of the conserved
tryptophan residue of the WPD-loop (1). As the WPD-loop moves from open to closed, the
tryptophan side chain moves within a hydrophobic pocket directly under the active site.
The exact position of the tryptophan side chain, and the angle at which it moves within the
hydrophobic pocket, are different for each PTP that has been crystallized. The residues that
line the hydrophobic pocket are not conserved, nor are they in the same place in all PTPs.
It was hypothesized that WPD-loop residues and their interaction with the hydrophobic
pocket play a major role in the movements of the WPD-loop. The WPD-loop movement
has been shown to be linked to the catalytic activity of PTPs(2).
Any mutation to the tryptophan of the WPD-loop of YopH significantly lowers the
activity of the enzyme, by two orders of magnitude or more, and removes general acid
catalysis, demonstrating that the tryptophan residue plays a key role in the enzyme’s
activity (3-5). PTP1B, however, does not show such drastic effects and tolerates
conservative mutations to this residue (6, 7). In PTP1B the conservative mutation to
phenylalanine (F) lowers the activity by only two-fold, and the general acid catalysis is not
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lost. The bell-shaped curve of the pH rate profile is indicative of a mechanism with two
key residues and their protonation states. As the solution becomes too acidic, the cysteine
in the active site becomes protonated reducing the catalytic rate and forming the acidic
limb of the bell. Inversely, as the solution becomes too basic, the aspartic acid that acts as
the general acid to neutralize the oxyanion formed in the first step of the mechanism, will
be deprotonated reducing the catalytic rate and forming the basic limb. Thus, the presence
of a basic limb in the pH rate profile shows that general acid catalysis is fully functional.
YopH is intolerant of mutations to the tryptophan of the WPD-loop, as seen in the
pH rate profile in which the basic limb of the bell shaped curve is greatly reduced in W354F
and eliminated in the W354A (8). In contrast, PTP1B shows a full basic limb for both
W179F and W179A, meaning both retain functional general acid catalysis (Figure 4-1). In
YopH the WPD-loop of the W354F mutant is stuck in a quasi-open position, which is the
cause of the loss of general acid catalysis. The phenylalanine side chain can move slightly,
however, this motion is limited and restricted to the front of the hydrophobic pocket. This
was shown by x-ray crystallography structures of both the ligand free and vanadate bound
structures(3). In both the ligand free and ligand bound structures the aromatic ring of the
phenylalanine occupies the same position as the five-membered ring of the indole side
chain in the open position of the native enzyme (Figure 4-2). In the corresponding mutant
of PTP1B the WPD-loop movement is able to assume the normal open and closed positions
and the phenylalanine also moves within the hydrophobic pocket as shown by the x-ray
crystallography structures(4). The PTP1B W179F mutant was crystalized with vanadate in
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the active site and showed the WPD-loop in the closed position, and in the absence of any
bound ligands present, the WPD-loop is in the open position.

Figure 4-1: A comparison of YopH pH rate profile for WT W354F and W354A and
PTP1B pH rate profile for WT W179F and W179A shows that PTP1B is tolerant of
mutation to the Tyr on the WPD-loop while YopH is not. On the left is the pH rate
profile of PTP1B. The WT PTP1B shows the fastest rates and also has the bell shaped
curve indicative of both general acid catalysis and the nucleophilic cysteine at the bottom
of the active site. The PTP1B W179F lowers the rate by a factor of two and keeps the bell
shaped curve. The PTP1B W179A lowers the rate by two hundred-fold and keeps general
acid catalysis. On the right YopH WT is the fastest and shows the full bell shaped curve.
The YopH W354F mutation lowers the catalytic activity by over two orders of magnitude
and the basic limb of the bell-shaped curve is almost gone, showing that general acid
catalysis has been impaired. The YopH W354A mutation lowers the catalytic activity by
over two orders of magnitude and the basic limb of the bell-shaped curve is gone, showing
that general acid catalysis has been lost (3, 9).
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Table 4-1: A comparison of the
residues that line the
hydrophobic pocket that the
tryptophan of the WPD-loop
slides into, between the PTPs
YopH and PTP1B.
YopH

PTP1B

L285

L109

V351

Y175

V360

P184

L368

F190, F193

R403

R221

L413

F224

The difference in tolerance of mutation to the tryptophan of the WPD-loop between
PTP1B and YopH, is connected to how the tryptophan side chain interacts with the
surrounding residues in the hydrophobic pocket.

The hydrophobic pocket lies directly

below the active site. The conserved arginine 409 for YopH or 221 in PTP1B that helps
stabilize the negative charge of the phosphate substrate is also the barrier between the active
site and the hydrophobic pocket. The guanidinium group of this arginine plays a key role
in catalysis and is conserved throughout the family because of it. The propyl side chain that
links the backbone and the guanidinium group is the boundary between the active site and
the hydrophobic pocket, and while this catalytic arginine is conserved, the rest of the
pocket’s residues are not (Table 4-1).
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How the tryptophan side chain interacts with the hydrophobic pockets residues is different
for PTP1B and YopH WT and their respective phenylalanine mutants. In Figure 4-2 a slice
of the hydrophobic pocket that is in the same plane as the flat indole ring of the tryptophan
side chain, or the aromatic ring of the phenylalanine in the mutants, shows the surrounding
area available within the hydrophobic pocket (Figure 4-2). In PTP1B WT, the tryptophan
side chain moves down farther into the hydrophobic pocket in a shifting right position and
the flat indole rings stays within the same plane during WPD-loop motion. During loop
motion in YopH WT, the tryptophan side chain moves down farther into the hydrophobic
pocket in a shifting left position, and the plane of the indole ring also rotates left 43.9°.
This rotation is necessary due to the shape of the hydrophobic pocket, which, in YopH, is
more restricted and therefore the indole side chain must rotate as it moves into and back
out of the hydrophobic pocket during WPD-loop motion. In comparison, the more open
hydrophobic pocket of PTP1B allows a straightforward movement of the tryptophan side
chain.
In the PTP1B W179F ligand free structure with the WPD-loop in the open position,
the phenyl ring sits directly in the middle of the two rings that make up the indole side
chain in the wild type enzyme. In relation to the hydrophobic pocket the phenyl ring sits
towards the front, and 15 degrees twist to a different plane as the indole ring. The ligand
bound structure with the WPD-loop in the closed position also has
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Figure 4-2: A comparison of a slice of the hydrophobic pocket that the tryptophan
residue slides farther into as the WPD-loop closes, between PTP1B and YopH WT
and tryptophan to phenylalanine mutants. Hydrophobic pocket of the conserved
tryptophan in the hinge of the WPD-loop, and orientations of the Trp in the native and Phe
in the mutant PTPs in open and closed WPD-loop forms. The arrows indicate the
movement direction of the Trp or Phe upon WPD-loop closure. These pictures were made
from PTP1B and YopH structures superimposed considering the P-loop region, no rotation
was applied between each representation. The hydrophobic pockets for all representations
are those for the closed or quasi-open (YopH W354F) WPD-loop conformations. The PDB
IDs used to generate each structure were: (a) PTP1B wildtype: 2CM2 (ligand-free form,
open WPD-loop), 3I80 (VO4 bound, closed WPD-loop); (b) PTP1B W179F: 3QKP
(ligand-free form, open WPD-loop), 3QKQ (VO4 bound, closed WPD-loop); (c) YopH
wildtype: 1YPT (ligand-free form, open WPD- loop), 2I42 (VO4 bound, closed WPDloop); (d) YopH W354F: 3F99 (ligand-free form, quasi-open WPD-loop), 3F9A
(WO4 bound, quasi-open WPD-loop) (10).

the phenyl ring sitting directly in the middle of the indole ring of the native enzyme, but in
the same plane. The area of the PTP1B hydrophobic pocket has space for the both the
tryptophan and phenylalanine side chains to move back and forth between the open and
closed positions, even though in the phenylalanine mutant the alpha and beta carbons are
0.5Å farther into the active site than the native tryptophan in the closed position.
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In YopH W354F the ligand free structure with the WPD-loop in the quasi open
position has the alpha carbon 0.8Å away from tryptophan’s alpha carbon, when in the open
position, but the gamma carbons are in the same place. This forces the six-membered
aromatic ring of the phenylalanine to occupy the same place as the five-membered ring of
the indole side chain, closer to the entrance of the hydrophobic pocket, where there is less
space for it. In the ligand bound structure with the WPD-loop still in the quasi open
position, the phenylalanine ring has moved slightly, 1.0Å to the right, but the alpha carbon
is in the same place as the alpha carbon of the tryptophan in the ligand free structure. This
slight movement brings the phenyl ring into the same plane as that of the YopH WT in the
open position. The phenyl ring sits in the middle of the indole ring, just like the PTP1B
open WPD-loop structures, where PTP1B W354F was aligned with PTP1B WT showing
the phenyl ring in the middle of the indole ring.
The hydrophobic pocket in YopH WT has very little extra room for movements
outside of the specific path in which the indole side chain moves. When the slice within
the hydrophobic pocket is changed to match the plane of the indole side chain when the
WPD-loop in the open position, we can see that there is a residue that constricts the area
of the hydrophobic pocket on this plane, and as a result, the larger six-membered
phenylalanine ring is obstructed from sliding into the hydrophobic pocket, forcing the
WPD-loop to stay in the quasi open position even with a ligand bound in the active site.
This is also seen with other conservative mutations in YopH W354H and W354Y, which
also show the WPD-loop in the quasi open position with and without a ligand bound in the
active site, although the reasons in the W354H case are different, as discussed in chapter
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2. This quasi open position of the WPD-loop also causes loss of general acid catalysis and
the corresponding pH rate profile shows the loss of the basic limb as well as a 100-fold
decrease in rate.
In an attempt to explore how individual residues forming the interior of the
hydrophobic pocket might affect WPD-loop motions differently in YopH and PTP1B, a
series of mutagenesis experiments were carried out in which residues lining this pocket
were mutated into their corresponding residues in PTP1B, and the effect on catalysis was
measured.

Materials and Methods
Protein Expression and Purification
The YopH L368A mutant was made using the Qiagen Quickchange lighting site directed
mutagenesis kit. The primers were designed according to the direction in the protocol
where both primers have the changed sequence in the middle (Table 4-2). For the rest of
the YopH mutants L368F, T365F, Q412T, and L368F plus T365F, were made using the
Q5 site directed mutagenesis kit. The primers were designed using the NEB website
NEBasechanger program, with all primers shown in Table 4-2. The primers are shown with
capital letters for the nucleotides except where the sequence has been mutated, which are
shown in lower case letters. The YopH W354F mutant was made as previously descried
and used as template DNA for double mutants containing an altered hydrophobic pocket
and F in place of W (11). For the single mutants, YopH WT DNA was used as the template
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and the correct primers were added to the PRC to give the following mutations: L368A,
L368F, T365F, and Q412T. For the double mutants with YopH W354F, the template DNA
was YopH W354F and the same primers were used to mutate their respective residues, to
give: W354F L368F, W354F L368A, W354F T365F, and W354F Q412T. For the YopH
L368F, T365F double mutant, the confirmed YopHL368F mutant DNA was used as the
template DNA and the YopH L368F T365F primers were used. For the triple mutant YopH
W354F T365F L368F, the confirmed double mutant YopH W354F L368F DNA was used
as the template DNA and the YopH L368F T365F was used to synthesize the YopH W354F
T365F L368F.
The protein purifications for the mutants were carried out as previously described
for YopH WT, but following is a brief overview (12). The DNA was transformed into
BL21 codon plus cells and let grow overnight on a LB culture plate with AMP at 37ºC.
One colony on the plate was placed into 5 mL of LB media containing AMP and let grow
overnight. In the morning, 1 L of LB media with 100 µg/mL AMP was inoculated with the
5 mL growth and shaken at 180 RPM and 37°C for about 5 hours until the OD600
reached0.8-1.0. The 1 L growths were then induced with 100mg of IPTG and moved to a
room temperature shaker and shaken at 180 RPM for 18h. The cells were then harvested
by centrifugation at 8K RPM for 15 minutes at 4C and stored in the -80C freezer.
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Table 4-2: List of all the primers used for mutagenesis.
Matched DNA in capital letter, miss matched/ mutated sequence in lower case.
Enzyme Mutation
Primers
GCTCTGAAGTTACCAAGGCAgcCGCTTCACTGGTA
YopH_L368A_Forward
GATCAAAC
GTTTGATCTACCAGTGAAGCGGCTGCCTTGGTAA
YopH_L368A_Reverse
CTTCAGAGC
YopH_L368F_Forward

TACCAAGGCAtTCGCTTCACTG

YopH_L368F_Reverse

ACTTCAGAGCTGACTGCG

YopH_T365F_Forward

CTCTGAAGTTttcAAGGCACTCGC

YopH_T365F_Reverse

CTGACTGCGGTCTGATCG

YopH_Q412T_Forward

CCGTACTGCGacaCTGATTGGCGC

YopH_Q412T_Reverse
YopH_L368F_
T365F_Forward
YopH_L368F_
T365F_Reverse

CCAACACCCGCACGGCAA
CTCTGAAGTTttcAAGGCATTCGCTTC
CTGACTGCGGTCTGATCG

The cells were removed from the freezer and kept on ice at 4C during lysis. The
cells were resuspended in the lysis buffer, 100 mM NaOAc, 1 mM DTT, 1 mM EDTA, pH
5.5, and one EDTA-free protease inhibitor cocktail tablet for every 50 mL. The cells were
lysed via sonication in a metal beaker at 60% power and 60% pulse for 15 pulses then
stirred on ice for 30 minutes, this was repeated 8 times. The lysate was then centrifuged for
50 minutes at 18K RPM at 4°C. If the protein was insoluble and therefore found in the
pellet, 10% glycerol was added and the procedure was started again, and if it was still
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insoluble, was marked as such. The supernatant was collected then loaded into the superloop to be loaded on to the columns. The Q-column and S-column were hooked up to the
FPLC machine in that order and washed with 2M NaCl until the absorbance at 280nm and
the conductivity were level. The columns were then equilibrated with buffer A, 100 mM
NaAc, 1 mM DTT, 1 mM EDTA, pH 5.5, and pump 2 was primed with buffer B, 100 mM
NaAc, 500 mM NaCl, 3 mM DTT, 1 mM EDTA, pH 5.5. The columns were then loaded
via the super-loop at a rate of 1mL per minute. After loading was complete the Q-column
was removed and 10 ml of buffer A was washed over the S-column. Then a 150 mL
gradient was started to elute the protein from the column. Finally, the column was washed
with 10 ml of buffer B then 10 mL of buffer A. The fractions of 150 mL gradient that show
UV absorbance at 280 nM were activity tested by mixing 50 uL 40mM p-NPP, 100 uL
buffer and 100 uL from each fraction. The fractions showing activity were also run on a
12% SDS page gel to test for purity and to make sure the isolated protein is the correct
weight. The protein was then concentrated and flash frozen with liquid nitrogen for kinetics
and stored in the -80ºC freezer.
Kinetics
Kinetics for all mutants were run at room temperature (23ºC). The concentrated
stock enzyme was slowly cooled on ice and diluted with water, then diluted with buffer
base mix (100 mM sodium acetate, 100 mM Tris, 100 mM and Bis-Tris) at the appropriate
pH. The substrate para-nitrophenylphosphate (p-NPP) was synthesized as the
dicyclohexylammonium salt as described in chapter 3. A stock solution of pNPP was
dissolved in buffer base mix to a concentration of 40 mM and then the pH was checked
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and adjusted by titration with acid or base. The product, 4-nitrophenol, will be ionized at
high pH, giving the compound a yellow color with an extinction coefficient of 18000 M1

cm-1 at 400 nM. End point kinetics were run using a 96 well plate by mixing different

amounts of buffer with the same pH p-NPP solution. Substrate concentration ranged from
0.25-25 mM p-NPP. The enzyme was diluted to anywhere between 100-0.1 µM and was
then added to the wells and, after a period of time ranging from 5-30 minutes, the solution
was quenched with 10 N sodium hydroxide, which stopped the reaction and brought the
pH above 9 so that all of the hydrolyzed 4-nitrophenol was in the ionic form. A blank was
also made with the same concentration of substrate for each well and instead of enzyme,
more buffer was added and was also quenched with 10N NaOH this gave the background
absorbance for each well without enzyme. The absorbance for each well was then taken
and the blank well was subtracted to give the total absorbance produced by p-nitrophenol
product formed by the enzyme. Each YopH mutant was tested at pH 5.5, the pH-optimum
for the WT enzyme, at a temperature of 23°C, in buffer base mix. The corrected absorbance
was converted to concentration using the Beer-Lambert Law, where A is the absorbance,

ɛ is the extinction coefficient, l is the path length traveled, and c is the concentration
Equation 1. The points were then fitted to the Michaelis-Menten equation where v is the
rate in µM/s (unless otherwise stated), and S is the substrate concentration.

A=ɛlc

Equation 1

v = Vmax[S] / (KM + [S])

Equation 2
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Results and Discussion
The protein expression and purification for the single YopH L368A mutant worked
as well as for the wild type YopH. The protein came off the S column gradients at about
90% purity and was concentrated to give a high yield of 5 mL of 4 mg/mL of protein. The
YopH L368A mutant was then kinetically tested and showed to be very active with, a kcat
(s-1) of 358 ± 37, and the KM (mM) of 6.2 ± 0.2. These are comparable to the WT YopH
numbers, with the KM being a little higher than WT and the kcat reduced

Table 4-3: kinetic data for mutants compared to WT YopH. All data were
collected in buffer base mix at pH 5.5 and 23°C
Enzyme mutation
YopH Wt
YopH L368A
YopH L368F
YopH T365F
YopH Q412T
YopH W354F
YopH W354F L368A
YopH W354F L368F
YopH W354F T365F
YopH W354F Q412T
YopH T365F L368F
YopH W354F T365F L368F

kcat (s-1)

KM (mM)

601
358 ± 37
0.35±0.11
0.21±0.03
0.75±0.1
2.96
0.130±0.0017
0.693±0.047

2
6.2 ± 0.23
20 ± 8
11.3 ± 2.6
10.8 ± 2.3
4.82
6.1 ± 1.4
14.2 ± 3.2

0.0284 ±0.0045
0.15±0.021

11.8 ± 3.3
10.3 ± 2.6

0.64±0.12

9.7 ± 3.4
insoluble
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by almost half (Table 4-3). This showed that while the catalytic rate has dropped slightly
there seemed to be no other significant problems with the mutation to remove one of the
side chains in the hydrophobic pocket.
With the initial test to remove one of the hydrophobic residue side chains from
YopH WT hydrophobic pocket being a success, the rest of the mutation primers were
ordered. The DNA mutations were carried out using the new Q5 mutagenesis kit, which
worked very well, only one of the initial PCR reaction had to be redone, and all mutations
were made within four rounds of PCR. The cells for the single mutants were grown at the
same time and storied in the negative 80°C freezer. The YopH L368F mutant purification
went smoothly and worked just like the YopH WT with no needed glycerol in the buffers,
but, when tested kinetically, showed a drastically lower rate than the YopH L368A mutant,
with a kcat (s-1) of 0.35 ± 0.11, and the KM (mM) at 20 ± 8. While the removal of the side
chain in L368A showed promising results, replacing the side chain with the one from
PTP1B showed significantly reduced rates. This could have been caused by overcrowding
of the hydrophobic pocket which restricted movement of the W354 indole ring and
therefore the entire WDP-loop. The other two single mutants, T365F and Q412T, were
purified and kinetically tested. The purifications went smoothly, but the kinetic results
again showed that the catalytic rates were drastically lower than the native enzymes and
were less than one per second (Table 4-3). This again could be because the indole side
chain of W354 residue was no longer mobile in the hydrophobic pocket. The kinetic data
is very similar to the W354A where the indole ring had been completely removed and loss
of general acid catalysis is evident.
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Going on the theory that the smaller W354F mutation might move more easily into
the altered hydrophobic pockets, each of the double mutations were expressed and grown
in E.coli. The purification of the double mutants proved to be problematic. For YopH
W354F L368A, the purification was successful without glycerol, but the yield of protein
was less than half that of the single mutants. With the rest of the double mutants most of
the protein was insoluble and found in the pellet despite the use of 10% glycerol through
the entire lysis and purifications steps. The soluble protein that was successfully purified
for each of these mutants was kinetically tested to see if catalysis had been restored, but all
measured kcat values were very low, less than one per second. For the last mutant, YopH
W354F T365F L368F, purification was unsuccessful; even with increasing the amount of
cells at the start and adding glycerol, all of the protein was present in the pellet, so no
kinetic data was achievable.
Conclusions
While the initial test of replacing L368 with the smaller alanine showed no
significant change to catalysis, replacing any of the hydrophobic pocket residues of YopH
with corresponding ones from PTP1B resulted in significant loss of catalytic activity. The
single mutations showed no significant aggregation or insolubility in the purification, but
the catalytic rates were each over three orders of magnitude slower than that of the wild
type. This shows the importance of the hydrophobic pocket residues for catalysis because
even one changed residue had a similar effect on the rate as removing the general acid
catalysis.
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If the new pocket in the mutants was structurally closer to that of PTP1B, then it
was theoretically possible that the W354F smaller side chain might fit within the new
hydrophobic pocket and restore mobility to the WDP-loop, and catalytic activity to the
enzyme. However, the W354F double mutants all showed significant loss of overall yield
due to insolubility, presumably to mis-folding and/or aggregation. What protein was
purifiable still showed reduced catalytic rates of less than one per second. The triple mutant
that would most resemble PTP1B, the W354F T365F L368F, was completely insoluble.
Thus, while the PTP1B hydrophobic pocket looks to be more open than that of YopH, the
simple replacing of residues in YopH seemed to do two things: one, make the hydrophobic
pocket more congested instead of less, causing the catalytic rate to drop by three orders of
magnitude; and, secondly, if too many changes are made the protein becomes insoluble.
This shows how important the interactions of the hydrophobic pocket with the indole side
chain of the tryptophan on the WPD-loop are, and, the identity of these residues to proper
folding and protein solubility. For the expression of full catalytic rate the tryptophan must
be able to move within the hydrophobic pocket to ensure that the WPD-loop can go from
open to closed position for catalysis.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS

1. Overall Summary
Overall the work covered in this dissertation helped to improve the understanding
of the PTPs and specifically the role of the WPD loop dynamics in their catalytic rates. The
WPD-loop is a mobile loop in classical PTPs that brings a catalytic general acid into the
active site and then 10.6 Å away from it. The rate of WPD-loop movement differs among
members of the PTP family, by two orders of magnitude, and in some PTPs it seem to be
not dynamic at all, and only in the closed, catalytically active position. In order to tease out
how these enzymes’ catalytic rates can vary over three orders of magnitude when their
active sites are superimposable, and catalytic residues are the same, the WPD-loop and
surrounding residues were examined. The first hypothesis that having a static WPD-loop
with general acid always in the catalytically active position would logically result in the
fastest rates, was proven wrong, as dynamic WPD-loop containing enzymes like YopH and
PTP1B are faster than enzymes with static WPD-loops or IDP-loops like SsoPTP. With
the help of collaborators using protein NMR to get real time data on WPD-loop dynamics,
the rates of the WPD-loop opening and closing were measured and compared with the
catalytic rates. A correlation was found between the WPD-loop closure rate and the
catalytic rate of cleavage of the phospho-tyrosine bond, the first step. This dissertation
shows that both the WPD-loop residues and their interactions with surrounding residues
play a major role the catalytic rate as well as the dynamics of the WPD-loop.
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2. The YopH W354H and W354Y Mutants
In looking specifically at the tryptophan (W) of the WPD-loop, mutations to this
residue have different effects in PTP1B as opposed to YopH. PTP1B is tolerant of
conservative and even non-conservative mutations to this residue. There is no change in
the mechanism of catalysis, which means that general acid catalysis is retained. The rates
of PTP1B W179 mutants, while lower than the wild type, are only reduced by factors of
from two to ten-fold, not orders of magnitude. On the other hand, YopH is intolerant of
even the most conservative mutations; F, Y and H, that keep an aromatic side chain in place
of the indole of the tryptophan. This was confirmed by the X-ray crystal structures of the
ligand-free and ligand-bound forms for all three conservative mutations F, Y and H, to the
W354 residue. In the WT of both PTP1B and YopH, crystal structures in which a ligand is
in the active site show the WPD-loop in the closed position, and, if there is no ligand in the
active site, crystal structures show the WPD-loop in the open position. The YopH W354F
mutated side chain is found in the same position of the hydrophobic pocket as the indole
ring of the wild type, in both the ligand-bound and ligand-free structures. This causes the
WPD-loop to be in the quasi open position for all structures. The quasi open WPD-loop
position keeps the general acid out of the active site, therefore removing it from the
catalytic mechanism, and reduces the rate of catalysis by three orders of magnitude.
In the X-ray crystal structure of the YopH W354 mutants with vanadate as the
ligand, which have the WPD-loop in the quasi open position, a novel divanadate glycerol
ester adduct is present. Vanadate oligomerization is common under biological conditions,
but all crystal structures of the native phosphatases that have been solved show only the
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monomeric form bound in the active site. This precedent of finding divanadate and a
divanadate glycerol ester in the active site in the quasi-open crystal structures, instead of
monomeric vanadate, shows that more stable oligomers and esters of vanadate can indeed
bind to the active site, and compete as an inhibitor. The divanadate glycerol ester is
stabilized by additional hydrogen bonds in the active site compared to the monomeric
vanadate, and therefore should be better inhibitors. In the native phosphatases with full
catalytic activity, the divanadate species would be cleaved by the enzyme, leaving only the
monomeric vanadate to be observed in the final structures. Vanadate is a strong inhibitor
of phosphatases, and the monomeric form was thought to be main contributor to this
inhibition. Even though vanadate readily oligomerizes under biological conditions there
was no previous evidence that higher order oligomers could bind. This documentation of
binding of higher order vanadate oligomers to phosphatases implies that higher orders of
vanadate also contribute to this strong inhibitory effect.

3. Hydrophobic Pocket Mutants
To further investigate the differences between PTP1B tolerance of conservative
mutations to the tryptophan in the WPD-loop, and YopH’s intolerance, the hydrophobic
pocket within which the indole ring of the tryptophan moves during WPD-loop motion was
examined. While the catalytic residues and overall 3-dimensional shape of the backbones
of PTPs are highly conserved, the rest of the residues are not. Investigations into the how
the indole ring moves within the pocket and interacts with the residues that line the
hydrophobic pocket showed significant difference between PTP1B and YopH. The PTP1B
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hydrophobic pocket is overall more open and the indole ring moves back and forth within
the same plane. The YopH hydrophobic pocket is tighter and the indole ring rotates 43.9°
to a different plane and moves farther into the pocket during the change from the open to
the closed WPD-loop position. This rotation is required for the fit of the large indole ring
side chain. Mutations where made to the hydrophobic pocket of YopH in an attempt to
transform it into a more open space like PTP1B, to see if mobility of the WPD-loop could
be restored to the YopH W354F mutant. These mutations dropped the activity by 3 orders
of magnitude from the wild type YopH and one order of magnitude from the YopH W354F
mutation, and many of them had solubility issues, presumably from misfolding. This shows
that the tryptophan’s indole side chain interactions with the hydrophobic pocket is
important for catalytic activity and stability of the protein structure. The movement of the
WPD-loop from open to the closed position is dependent on the interactions of the
tryptophan in the hydrophobic pocket, and therefore affects the catalytic rate is as well.

4. YopH PTP1B WPD-loop swapped Chimeras
In a different approach to understanding how the WPD-loop dynamics affect the
catalytic rate, a WPD-loop swapped chimera was made. This hypothesis was that if the
residues of the WPD-loop control its movement and therefore the catalytic rate of the
enzyme, then taking the WPD-loop from PTP1B and swapping it into YopH in place of its
original WPD-loop will result in a new chimera with rates similar to the rate of PTP1B. If
the WPD-loop residues do not control the rate of the WPD-loop movement, and the rate is
determined by other factors, then the catalytic rate should stay the same as that of YopH.
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Neither of these straightforward hypotheses proved to be true, for the final chimera 3 was
less active than both parents, showing that not only do the residues that make up the WPDloop affect the rate, but how these residues interact with the surrounding protein is probably
also important.
Making a chimera of PTP1B and YopH that retains its tertiary structure and
therefore catalytic activity is not as simple as cut and paste. Initial attempts at synthesizing
a chimera ended with insoluble protein, so the area of the swapped region was examined
and adjusted in order that no hydrophobic and hydrophilic residues were clashing, and that
hydrogen bonding was maintained as much as possible for stability. But even stable soluble
protein may not be catalytically active, as was seen in chimera 2. The X-ray crystal
structures of both the ligand-bound and ligand-free forms showed the transposed WPDloop in a novel, non-catalytically active position. The alpha helix at the end of the WPDloop was extended by a half turn, which is three residues farther into the WPD-loop. This
extra half turn means that the alpha helix starts on the far side of the WPD-loop, making
the loop residues in the WPD-loop cross over the alpha helix at the start of the alpha helix.
This extra length to the start of the alpha helix and the loss of the 3 residues caused the
WPD-loop to straighten out, moving the general acid out of the active site, and causing
loss of general acid catalysis. The rate was reduced by over four orders of magnitude from
that of YopH WT and two orders of magnitude slower than PTP1B WT. All the data
collected, including the crystal structures of both ligand-bound and ligand-free forms, the
low catalytic rate, and the flat pH-rate profile, suggest that the YopH chimera 2 is stuck in
this catalytically unproductive form.
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Again, the swapped region of YopH chimera 2 was reexamined in the novel
extended alpha helix structure to see what could have caused its formation. A number of
mutants were made and kinetically tested, the most successful one being that in which the
swapped region was shortened by two residues, which showed activity and is called YopH
chimera 3. While the catalytic activity was enhanced, it was still two orders of magnitude
slower than YopH WT and 10-fold slower than PTP1B. The pH-rate profile showed a full
bell-shaped curve which indicated full restoration of general acid catalysis, and this
conclusion is also supported by the KIE data. The X-ray crystal structures show that while
it can form the open WPD-loop position, it can also form the unproductive extended alpha
helix form. This explains both the restoration of general acid catalysis and the lower rates.
Fluctuations between the catalytically active form, the open form and the extended alpha
helix form will slow the overall activity down, as less of the enzyme is in a productive
conformation. Thus, in conclusion, the formation of a YopH chimera requires an in-depth
study of the tertiary structure of both parent proteins along with trial and error to form this
new YopH chimera 3. This new YopH chimera 3 is a unique enzyme with its own
mechanistic timing and rates.
In conclusion, the WPD-loop residues and their interactions with the hydrophobic
pocket residues and other surrounding residues, play a major role in the dynamics of the
WPD-loop, and the catalytic rates of the PTP1B and YopH.

5. Future work and ideas
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Future experiments to help better understand why the WPD-loop movements differ
with in the family are underway, or proposed herein. Mutations to PTP1B’s hydrophobic
pocket might transform it into a similar form as that of YopH when the W179F mutation
is added, to see if the WPD-loop can adopt the quasi open position. This would confirm
that the more confined space of the hydrophobic pocket is the cause of the quasi-open
position of the WPD-loop, as was hypothesized. Collaborators are looking into more realtime studies, using protein NMR, of the dynamics of WPD-loops in other members of the
PTP family including PTP1B, SsoPTP and YopH chimera 3. NMR experiments are
continuing on YopH chimera 3 and will shed light on how the rates of the WPD-loop has
changed. Initial NMR results on chimera 3 have shown the closed, catalytically active
WPD-loop conformation, which has not been revealed in any of the X-ray structures. This
NMR data with other results will be submitted for publication later this year. NMR
investigations of WT SsoPTP to look for evidence of any conformations besides the
confirmed closed position are also underway. In PTP1B, several mutations on the WPDloop, such at P185V and P180A and others, have been shown to change the catalytic rate.
NMR studies are being used to determine whether the kinetic changes result from
alterations to the WPD-loop rates. KIEs will also be carried out to see whether the catalytic
mechanism or transition state has been changed by these mutations.
X-ray crystallography is normally done at very low temperatures, under liquid
nitrogen cooling at 75K, so a single still picture of the protein can be captured and
minimizing crystal damage from the X-rays. Recent experiments with increasing the
temperatures of the data collection for X-ray crystallography are in progress in Dr. James
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Fraser’s lab at the University of San Francisco. The X-ray crystal structures have been
solved for WT PTP1B at 100K, 180K, 240K and 278K, and have been presented at a
conference, but are not yet published. This technique could be used to capture the WPDloop in other forms than just the open and closed positions, and possibly to get a full range
of motions as the WPD-loop moves from open to closed. This could be used to probe how
the YopH chimera 3 is able to form the extended alpha helix in solution and how it is able
to get back into the catalytically active closed position again. A new chimera of PTP1B
with YopH’s WPD-loop is currently being designed and synthesized by a new graduate
student in the Hengge lab.
SsoPTP is a newly discovered thermophilic PTP that has so far showed no evidence
of mobility in its general acid-loop, based on published ligand-bound and ligand-free Xray crystal structures. SsoPTP does not have a classical WPD-loop but has an IDPsequence instead. This change in the conserved tryptophan residue as well has other
changes to the WPD-loop region could affect whether or not this acid loop undergoes
dynamic motion. Using this limited or lack of mobility as a starting point, mutations to the
enzyme that would allow its general acid-loop to become mobile could shed light directly
on how the mobility of the WPD-loop effects the catalytic
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Table 5-1: A comparison of the
residues that line the
hydrophobic pocket that the
tryptophan of the WPD-loop
slides into, between the PTPs
YopH and PTP1B.
YopH

PTP1B

L285

L109

V351

Y175

V360

P184

L368

F190, F193

R403

R221

L413

F224

rate. There are many possible experiments that would be carried out to accomplish this, for
instance single point mutation to the general acid-loop itself, such as changing the IPDloop into a WPD-loop with the I67W mutation. Alternatively, at the end of the IDP-loop
is a conserved proline that starts the alpha helix, while in YopH that residue is a valine.
Thus, a P73V mutation could change the start of the alpha helix and might make the loop
more mobile.
Mutation to the hydrophobic pocket YopH ran into many experimental problems,
but overall showed that it is important for catalysis. PTP1B has been shown to be more
tolerant of mutations to the tryptophan on the WPD-loop, and therefore, might be more
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tolerant of mutations to the hydrophobic pocket that the tryptophan moves in. Therefore,
mutations to the residues that form the PTP1B hydrophobic pocket to be similar those in
YopH (Table 5-1) might alter the WPD-loop dynamics or even trap the WPD-loop in the
closed position. Such a permanently closed mutant would then allow us to directly interpret
how the dynamics of the WPD-loop affect the rate of catalysis. Mostly likely we would see
the WPD-loop in the quasi open position which would be new for PTP1B, and confirm that
the hydrophobic pocket residues are what is cause this unique position.
With the discovery of SsoPTP, a stable and active PTP with an IPD-loop and no
known dynamics, a whole new range of WPD-loop swapped chimeras can be designed
(Table 5-2). The formation of WPD-loop IDP-loop swapped chimeras with PTP1B or
YopH can be made. Swapping the SsoPTP loop in YopH and testing it mobility would help
to understand how some WPD-loops are more mobile than others and whether the
differences are based on the WPD-loop residues only or the interaction of the residues with
the surrounding protein. The chimera of PTP1B with YopH WPD-loop is underway in the
Hengge lab, and herein a proposal for the formation of SsoPTP chimera with PTP1B and
YopH and the reverse. Table 5-2 shows the WPD-loops of PTP1B, YopH, YopH chimera
3 and SsoPTP, and proposed new chimeras. In YopH chimera 3 the bolded region shows
swapped region between PTP1B and YopH. For the design of the swapped chimeras for
PTP1B or YopH with SsoPTP, the bolded region of SsoPTP would be a good place to start.
Because SsoPTP does not have a residue corresponding to G352 in YopH, which is where
YopH chimera 3 starts, I propose starting at the next residue, N353 in YopH. For the end
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Table 5-2: WPD-loops alignment between YopH,
PTP1B and SsoPTP WT, and designs for SsoPTP
chimeras.
Enzyme

WPD-loops sequence

PTP1B
YopH
YChi3
SsoPTP

HYTTWPDFGVPESP
HVGNWPDQTAVSSE
HVTTWPDFGVVSSE
HI-PIPDGGVPSDS

SsoPTP-YopH

HI-NWPDQTAPSDS

SsoPTP-PTP1B

HI-TWPDFGVPSDS

YopH-SsoPTP

HVGPIPDGGVVSSE

PTP1B-Sso

HYTPIPDGGVPESP

of the swapped region I proposed stopping where chimera 3 ends on residue #359, because
this chimera showed catalytic activity and full WPD-loop motion. While this might result
in the extended alpha helix problem discussed earlier, it might not, and starting here would
mean less residues to exchange to minimize this potential problem as much as possible.
Once another active chimera is designed and found, NMR studies would help determine if
acid loop motion is present and how it has been affected.
The study of how dynamic movements on an angstrom level can affect the catalytic
rates of PTPs is a fascinating and expanding area. There is still much more to be learned.
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Supporting information for “Locked WPD-loops and divanadate esters
in two new tryptophan mutants of the protein-tyrosine phosphatase
YopH”
Gwendolyn Moise,a Nathan Gallup,b Anastassi N. Alexandrova,b,c Alvan C. Hengge,a and
Sean J. Johnsona
a

Department of Chemistry and Biochemistry, Utah State University, Logan, UT
84322-0300
b

Department of Chemistry and Biochemistry, University of California, Los
Angeles, CA 90095-1569
c
California Nanosystems Institute, University of California, Los Angeles, CA 900951569
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Parameter
Q(V1)
Q(V2)
Q(O1)
Q(O2)
Q(O3)
Q(O4)
Q(O5)
Q(O6)
Q(O7)
Q(S)
V1-S σ
V1-S π
V1-O1 σ
V1-O1 π
V1-O1 π
V1-O2 σ
V1-O2 π
V1-O2 π
V1-O3 σ
V1-O3 π
V1-O4
V2-O3 σ
V2-O3 π
V2-O4
V2-O5 σ
V2-O5 π
V2-O5 π
V2-O6 σ
V2-O6 π
V2-O7 σ
V2-O7 π
V2-O7 π
LP1(O1)
LP2(O1)
LP1(O2)
LP2(O2)

W354Y
W354Y
(prot O5)
(prot O6)
0.47465
0.48708
0.76664
0.75449
-0.61849
-0.62607
-0.30628
-0.31487
-0.58994
-0.58636
-0.50702
-0.52930
-0.78621
-0.45363
-0.34862
-0.68871
-0.69059
-0.66884
-0.08888
-0.12353
Bond Population (|e|)
1.83403
1.8705
1.88443
none
1.90565
1.91114
1.87089
1.96684
1.88911
1.88320
1.88759
1.89422
1.88058
1.89329
1.8546
1.93544
1.82461
1.86361
none
none
1.87661
1.91441
1.87459
1.87481
1.81815
none
1.89713
1.89748
1.93735
1.90635
1.94694
1.93080
none
1.94529
1.88926
1.94844
1.89482
1.95439
1.92971
1.9405
none
none
none
none
Lone Pair Populations (|e|)
1.88524
1.88134
none
none
1.87943
1.8793
none
none

W354F
(prot O5)
0.53678
0.67021
-0.65567
-0.69653
-0.71285
-0.57151
-0.93426
-0.60562
-0.47104
-0.32647
1.9257
none
1.92010
1.96595
none
1.93363
1.93024
none
1.94333
1.84156
none
1.88011
none
none
1.94947
none
none
1.91668
1.95853
1.96093
1.91373
1.96171
1.88231
1.64587
1.87018
1.68980
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LP1(O3)
LP2(O3)
LP1(O4)
LP2(O4)
LP3(O4)
LP4(O4)
LP1(O5)
LP2(O5)
LP1(O6)
LP2(O6)
LP1(O7)
LP2(O7)
LP1(S)
LP2(S)

1.80911
none
1.86524
none
none
none
1.90073
none
1.87294
none
1.89631
1.85063
1.93562
none

1.82386
1.67226
1.85103
none
none
none
1.87933
none
1.87673
none
1.89082
1.82884
1.93217
1.80825

1.84984
none
1.82748
1.69656
1.58339
1.45719
1.93082
1.88698
1.88890
1.65776
1.89344
none
1.95739
1.88237

Table 2-S1: Electronic structure parameters characterizing the vanadate complexes
shown in Figures 4A and 4B of the text. The identity of the protonated oxygen atom is
given in the top row. Calculated with NBO analysis showing atomic charges (Q) and
electronic populations of 2 center-2 electron bonds and lone pairs.

Figure 2-S1: The reference model compound designated EBIGIF in the Cambridge
database. Published in: Bhattacharyya, S., Batchelor, R. J., Einstein, F. W. B., and
Tracey, A. S. (1999) Crystal structure and solution studies of the product of the reaction
of beta-mercaptoethanol with vanadate, Can J Chem 77, 2088-2094. Computed
structural parameters are below.
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Parameter
Q(V1)
0.46843
Q(O1)
-0.50182
-0.1548
Q(S1)
-0.50182
Q(C1)
-0.50182
Q(C2)
-0.50182
Q(O2)
Q(O3)
-0.45385
Bond Population (|e|)
V1-O1
1.89604
V1-S1
1.90991
V1-O2 σ
1.9388
V1-O2 π
1.91833
V1-O2 π
1.91071
V1-O3 σ
1.90066
V1-O3 π
1.87842
V1-O3 π
1.96595
S1-C1
1.98145
O1-C2
1.98495
Lone Pair Populations (|e|)
O2
1.87055
O3
1.89439
S1-C1
1.86748

Table 2-S2: Electronic structure parameters characterizing the model complex
shown in Figure S1.
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Parameter
0.73270
Q(V1)
-0.55549
Q(O1)
-0.60835
Q(O2)
0.06489
Q(C1)
0.07603
Q(C2)
-0.46864
Q(O3)
-0.44764
Q(O4)
Bond Population (|e|)
V1-O1
none
V1-O2
none
1.98213
V1-O3 σ
1.98565
V1-O3 π
1.98258
V1-O4 σ
1.98928
V1-O4 π
1.98239
O2-C2
1.98292
O1-C1
Lone Pair Populations (|e|)
1.85325
LP1(O1)
1.72482
LP2(O1)
1.66989
LP3(O1)
1.90342
LP1(O2)
1.82588
LP2(O2)
1.61552
LP3(O2)
1.89244
LP1(O3)
1.63536
LP2(O3)
1.89461
LP1(O4)
1.62430
LP2(O4)

Table 2-S3: Electronic structure parameters characterizing the model complex
shown in Figure S2.
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Figure 2-S2: The reference model compound designated TOGQEL in the
Cambridge database. Published in: Zhang, B. Y., Zhang, S. W., and Wang, K. (1996)
Synthesis, characterization and crystal structure of cyclic vanadate complexes with
monosaccharide derivatives having a free adjacent diol system, J Chem Soc Dalton,
3257-3263. Computed structural parameters are below.
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A

Rate, V uM s-1 with vanadate + glycerol
Rate, V uM s-1 with glycerol
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Figure 2-S3: A plot showing the influence of glycerol on the inhibition by vanadate.
Top: The rate of p-NPP hydrolysis of YopH W354H where [pNPP]= 0.76 mM and VO4
= 32 µM over increasing glycerol concentrations. The X-ray crystal structure of both
mutants show a glycerol coordinated to the divanadate in the active site with and extra
hydrogen bond to one of the alcohols on the glycerol (Figure 5), but there is no
synergistic effect of glycerol on the inhibition by vanadate. Bottom: initial rate of YopH
W354H where [pNPP] = 1.97mM, [Glycerol] = 1.4 mM, over increasing concentrations
of inorganic phosphate. Significant cooperativity would be revealed by curvature of the
data with both inhibitors present, which was not observed.
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Figure 2-S4: The active site of YopH showing the difference in the position of the
general acid D356 in the WPD-loop closed YopH-vanadate complex, and the mutant
W354Y with its loop in the quasi-open position. The YopH WT with vanadate bound is
cyan; YopH W354Y with divanadate bound is magenta. The yellow dashed lines are
distances in Å. The figure shows a comparison of the distances of the catalytic aspartic
acid from the vanadate bridging oxygen, with the loop in a closed or quasi-open position.

137

PTPs

Substrate

kcat s-1

KM mM

WPD-loop dynamics

YopH

p-NPP

720

0.98

Flexible

PTP1B

p-NPP

52

0.12

Flexible

VHZ

p-NPP

3.9

8.3

Rigid

VH1

p-NPP

0.3

7.7

Rigid

Table 2-S4: An assessment of various PTPs and their different rates of hydrolysis
using the small molecule para-nitrophenylphosphate (p-NPP), as well as the
flexibility of the WPD-loop.
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Figure 3-S1: The α-helix extends into the flexible loop differently in the chimeras
than the WT enzymes. This shows how, in chimera 2, the end of the WPD loop is in the
extended α-helix position in both the ligand bound and ligand free structures. As a result,
in chimera 2 the general acid remains in an inactive position. The higher energy needed
to escape the inactive position, explains why the enzymatic activity is negligible in
chimera 2. Chimera 3 is able to get out of this inactive, extended α-helix position to
preform catalysis. While chimera 3 is still hindered by the extended α-helix position
shown in its ligand-bound X-ray crystal structure, its kinetic results show that its WPDloop can get into a catalytically functional closed position.

